研究

2025　 (Updated on 24 April 2025)

1. Koyanagi N, Hengphasatporn K, Kato A, Nobe M, Takeshima K, Maruzuru Y, Maenaka K, Shigeta Y, Kawaguchi Y. Regulatory mimicry of cyclin-dependent kinases by a conserved herpesvirus protein kinase. Proceedings of the National Academy of Sciences. 122(16):e2500264122. https://doi.org/10.1073/pnas.2500264122 (2025)

論文解説　ウイルスの生存戦略を司る分子模倣を解明 ―ウイルスキナーゼは宿主キナーゼの機能だけでなく、調節機構も模倣する―

2. Yamada Y, Sankoda N, Yamada Y. In Vivo Reprogramming Highlights Epigenetic Regulation That Shapes Cancer Hallmarks. Cancer Sci. https://doi.org/10.1111/cas.70067 (2025)

3. Kobiyama K, Utsumi D, Kaku Y, Sasaki E, Yasui F, Okamura T, Onodera T, Tobuse AJ, Sakkour A, Amiry AF, Hayashi T, Temizoz B, Liu K, Negishi H, Toyama-Sorimachi N, Kohara M, Sawasaki T, Takagi J, Sato K, Takahashi Y, Yasutomi Y, Ishii KJ. Immunological analysis of LC16m8 vaccine: preclinical and early clinical insights into mpox. eBioMedicine. 115:105703. https://doi.org/10.1016/j.ebiom.2025.105703 (2025)

論文解説　エムポックス（MPOX）に対する日本発ワクチンの免疫学―LC16m8ワクチン接種による免疫応答を初めて包括的に解析した研究成果を発表―

4. Yamamoto K, Nagatoishi S, Matsunaga R, Nakakido M, Kuroda D, Tsumoto K. Affinity-stability trade-off mechanism of residue 35 in framework region 2 of VHH antibodies with β-hairpin CDR3. Protein Sci. 34(4):e70095. https://doi.org/10.1002/pro.70095 (2025)

5. Iwatsuki-Horimoto K, Uraki R, Ito M, Wang T, Guan L, Halfmann P, Eisfeld A, Neumann G, Yamayoshi S, Kawaoka Y. Transmission of bovine H5N1 virus in a hamster model. J Virol. https://doi.org/10.1128/jvi.00147-25 (2025)

6. Koide S, Oshima M, Kamiya T, Zheng Z, Liu Z, Rizq O, Nishiyama A, Murakami K, Yamada Y, Nakajima-Takagi Y, Rahmutulla B, Kaneda A, Yokoyama K, Yusa N, Imoto S, Miura F, Ito T, Tamura T, Nerlov C, Yamashita M, Iwama A. Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the lifespan. Blood. https://doi.org/10.1182/blood.2024025776 (2025)

7. Weller C, Bartok O, McGinnis CS, Palashati H, Chang T, Malko D, Shmueli MD, Nagao A, Hayoun D, Murayama A, Sakaguchi Y, Poulis P, Khatib A, Erlanger Avigdor B, Gordon S, Cohen Shvefel S, Zemanek MJ, Nielsen MM, Boura-Halfon S, Sagie S, Gumpert N, Yang W, Alexeev D, Kyriakidou P, Yao W, Zerbib M, Greenberg P, Benedek G, Litchfield K, Petrovich-Kopitman E, Nagler A, Oren R, Ben-Dor S, Levin Y, Pilpel Y, Rodnina M, Cox J, Merbl Y, Satpathy AT, Carmi Y, Erhard F, Suzuki T, Buskirk AR, Olweus J, Ruppin E, Schlosser A, Samuels Y. Translation dysregulation in cancer as a source for targetable antigens. Cancer cell. https://doi.org/10.1016/j.ccell.2025.03.003 (2025) 

8. Izuka S, Komai T, Tsuchida Y, Tsuchiya H, Okamura T, Fujio K. The role of monocytes and macrophages in idiopathic inflammatory myopathies: insights into pathogenesis and potential targets. Frontiers in Immunology. 16:1567833. https://doi.org/10.3389/fimmu.2025.1567833 (2025)

9. Furusawa Y, Kiso M, Uraki R, Sakai-Tagawa Y, Nagai H, Koga M, Kashima Y, Hojo M, Iwamoto N, Iwatsuki-Horimoto K, Ohmagari N, Suzuki Y, Yotsuyanagi H, Halfmann PJ, Kamitani W, Yamayoshi S, Kawaoka Y. Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures. J Virol. 99(3):e0221724–24. Epub 2025 Feb 12. https://doi.org/10.1128/jvi.02217-24 (2025)

10. Park H, Kingstad-Bakke B, Cleven T, Jung M, Kawaoka Y, Suresh M. Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein. J Virol. 99(3):e0086724–24. Epub 2025 Feb 3. https://doi.org/10.1128/jvi.00867-24 (2025)

11. Ukaji T, Arai D, Tsutsumi H, Nakagawa R, Matsumoto F, Ikeda K, Nureki O, Kamiya K. AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model. JCI Insight. 10(5):e185193. doi: 10.1172/jci.insight.185193. https://doi.org/10.1172/jci.insight.185193 (2025)

12. Sato N, Nakano Y, Matsuki Y, Tomomatsu S, Li S, Matsuo Y, Inada T. Crucial roles of Grr1 in splicing and translation of HAC1 mRNA upon unfolded stress response. Nat Commun. 16(1):2172–1. https://doi.org/10.1038/s41467-025-57360-1 (2025)

13. Matsunaga R*, Tsumoto K. FASTIA: A rapid and accessible platform for protein variant interaction analysis demonstrated with a single-domain antibody. Protein Sci. 34(3):e70065. https://doi.org/10.1002/pro.70065 (2025)

14. Takashita E, Shimizu K, Kawakami C, Momoki T, Saikusa M, Ozawa H, Kumazaki M, Usuku S, Tanaka N, Senda R, Okubo I, Fujisaki S, Nagata S, Morita H, Miura H, Watanabe K, Nakauchi M, Matsuzaki Y, Watanabe S, Hasegawa H, Kawaoka Y. Impact of COVID-19 on Respiratory Virus Infections in Children, Japan, 2018-2023. Immun Inflamm Dis. 13(3):e70176. https://doi.org/10.1002/iid3.70176 (2025)

15. Yano S, Asami N, Kishi Y, Takeda I, Kubotani H, Hattori Y, Kitazawa A, Hayashi K, Kubo K, Saeki M, Maeda C, Hiraki C, Teruya R, Taketomi T, Akiyama K, Okajima-Takahashi T, Sato B, Wake H, Gotoh Y, Nakajima K, Ichinohe T, Nagata T, Chiba T, Tsuruta F. Propagation of neuronal micronuclei regulates microglial characteristics. Nat Neurosci. 28(3):487–498. https://doi.org/10.1038/s41593-024-01863-5 (2025) 

16. Nakatsukasa Y, Yamada Y, Yamada Y. Research of in vivo reprogramming toward clinical applications in regenerative medicine: A concise review. Regenerative therapy. 28:12–19. https://doi.org/10.1016/j.reth.2024.11.008 (2025) 

17. Kobayashi M, Kobayashi N, Deguchi K, Omori S, Ichinohe T. SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner. NPJ Vaccines. 10(1):40–z. https://doi.org/10.1038/s41541-025-01095-z (2025)

18. Oka E, Ueda Y, Yagi A, Machida M, Furuse Y, Tabuchi T. Challenges to promoting maternal respiratory syncytial virus vaccination in Japan. Vaccine. 48:126767. https://doi.org/10.1016/j.vaccine.2025.126767 (2025)

19. Lytras S, Lamb KD, Ito J, Grove J, Yuan K, Sato K, Hughes J, Robertson DL. Pathogen genomic surveillance and the AI revolution. J Virol. 99(2):e0160124–24. Epub 2025 Jan 29. https://doi.org/10.1128/jvi.01601-24 (2025)

20. Ise W, Koike T, Shimada N, Yamamoto H, Tai Y, Shirai T, Kawakami R, Kuwabara M, Kawai C, Shida K, Inoue T, Hojo N, Ichiyama K, Sakaguchi S, Shiroguchi K, Suzuki K, Kurosaki T. KLF2 expression in IgG plasma cells at their induction site regulates the migration program. J Exp Med. 222(5):e20241019. https://doi.org/10.1084/jem.20241019 (2025)

論文解説　抗体産生細胞の運命を決める仕組みを解明: 抗体応答が持続するワクチンの開発に期待

21. Suzuki T, Ogizawa A, Ishiguro K, Nagao A. Biogenesis and roles of tRNA queuosine modification and its glycosylated derivatives in human health and diseases. Cell chemical biology. 32(2):227–238. https://doi.org/10.1016/j.chembiol.2024.11.004 (2025)  

22. Yu X, Ni Z, Wang Y, Wang J, Deng G, Shi J, Kong H, Jiang Y, Tian G, Li C, Kawaoka Y, Chen H, Wang J. Claudin-11 plays a pivotal role in the clathrin-mediated endocytosis of influenza A virus. Sci China Life Sci. https://doi.org/10.1007/s11427-024-2856-y (2025)

23. Furuse Y, Komorizono R, Fujita N. Need to revisit culture isolation for detecting viraemia. Lancet Microbe. :101080. https://doi.org/10.1016/j.lanmic.2025.101080 (2025)

24. Hastie KM, Salie ZL, Ke Z, Halfmann PJ, DeWald LE, McArdle S, Grinyo A, Davidson E, Schendel SL, Hariharan C, Norris MJ, Yu X, Chennareddy C, Xiong X, Heinrich M, Holbrook MR, Doranz B, Crozier I, Kawaoka Y, Branco LM, Kuhn JH, Briggs JAG, Worwa G, Davis CW, Ahmed R, Saphire EO. Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP((1,2)) in a position elevated from the virion membrane. Nat Commun. 16(1):1293–2. https://doi.org/10.1038/s41467-025-56452-2 (2025)

25. Uraki R, Ito M, Kiso M, Iwatsuki-Horimoto K, Endo M, Yamayoshi S, Kawaoka Y. An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters. npj Viruses. 3(1):7. https://doi.org/10.1038/s44298-025-00096-y (2025) 

26. Uriu K, Kaku Y, Uwamino Y, Fujiwara H, Saito F, Genotype to Phenotype Japan (G2P-Japan) Consortium, Sato K. Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC. Lancet Infect Dis. 25(2):e61–7. Epub 2024 Dec 10. https://doi.org/10.1016/S1473-3099(24)00810-7 (2025)
    論文解説　オミクロンJN.1mRNAワクチンにより誘導される オミクロン亜株に対する液性免疫の効果

27. Ujiie K, Nakakido M, Kinoshita S, Caaveiro JMM, Entzminger CK, Okumura SCJ, Maruyama T, Miyauchi K, Matano T, Tsumoto K. Specific recognition mechanism of an antibody to sulfated tyrosine and its potential use in biological research. J Biol Chem. 301(2):108176. https://doi.org/10.1016/j.jbc.2025.108176 (2025)

28. Kakizaki M, Hashimoto R, Nagata N, Yamamoto T, Okura T, Katoh H, Kitai Y, Akahori Y, Shirato K, Ryo A, Takayama K, Takeda M. The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids. J Virol. 99(1):e0185324–24. Epub 2024 Nov 27. https://doi.org/10.1128/jvi.01853-24 (2025)

29. Kanno A, Tanifuji R*, Yoshida S, Sato S, Maki-Yonekura S, Takaba K, Kang J, Tono K, Yonekura K, Oguri H. Streamlined modular synthesis of saframycin substructure via copper-catalyzed three-component assembly and gold-promoted 6-endo cyclization. Beilstein Journal of Organic Chemistry. 21:226–233. https://doi.org/10.3762/bjoc.21.14 (2025)

30. Saegusa K, Tsuchida Y, Komai T, Tsuchiya H, Fujio K. Advances in Targeted Therapy for Systemic Lupus Erythematosus: Current Treatments and Novel Approaches. Int J Mol Sci. 26(3):929. doi: 10.3390/ijms26030929. https://doi.org/10.3390/ijms26030929 (2025)

31. Sekine R, Takeda K, Suenaga T, Tsuno S, Kaiya T, Kiso M, Yamayoshi S, Takaku Y, Ohno S, Yamaguchi Y, Nishizawa S, Sumitomo K, Ikuta K, Kanda T, Kawaoka Y, Nishimura H, Kuge S. G-quadruplex-forming small RNA inhibits coronavirus and influenza A virus replication. Communications Biology. 8(1):27. https://doi.org/10.1038/s42003-024-07351-7 (2025)

32. Imai M, Ueki H, Ito M, Iwatsuki-Horimoto K, Kiso M, Biswas A, Trifkovic S, Cook N, Halfmann PJ, Neumann G, Eisfeld AJ, Kawaoka Y. Highly pathogenic avian H5N1 influenza A virus replication in ex vivo cultures of bovine mammary gland and teat tissues. Emerging Microbes & Infections. 14(1):2450029. https://doi.org/10.1080/22221751.2025.2450029 (2025)
    論文解説　乳牛の乳房・乳頭組織におけるウシ由来H５N1高病原性 鳥インフルエンザウイルスの増殖性状を解明

33. Taguchi J, Yamada Y, Ohta S, Nakasuka F, Yamamoto T, Ozawa M, Yamada Y. A versatile in vivo platform for reversible control of transgene expression in adult tissues. Stem cell reports. 20(1):102373. https://doi.org/10.1016/j.stemcr.2024.11.003 (2025) 

34. Yang J, Song I, Saito M, Hartanto T, Ichinohe T, Fukuda S. Partially hydrolyzed guar gum attenuates symptoms and modulates the gut microbiota in a model of SARS-CoV-2 infection. Gut microbiome (Cambridge, England). 6:e1. https://doi.org/10.1017/gmb.2024.7 (2025)  

35. Ueki H, Wang I, Kiso M, Horie K, Iida S, Mine S, Ujie M, Hsu H, Wu CH, Imai M, Suzuki T, Kamitani W, Kawakami E, Kawaoka Y. Neutrophil adhesion to vessel walls impairs pulmonary circulation in COVID-19 pathology. Nat Commun. 16(1):455–0. https://doi.org/10.1038/s41467-024-55272-0 (2025)
    論文解説　免疫細胞が引き起こすCOVID-19の重症化機序を解明: ― 肺血管での異常な接着現象に着目 ―

36. Ishizaka A*, Tamura A, Koga M, Mizutani T, Yamayoshi S, Iwatsuki-Horimoto K, Yasuhara A, Yamamoto S, Nagai H, Adachi E, Suzuki Y, Kawaoka Y, Yotsuyanagi H. Dysbiosis of gut microbiota in COVID-19 is associated with intestinal DNA phage dynamics of lysogenic and lytic infection. Microbiology Spectrum. 13(1) https://doi.org/10.1128/spectrum.00998-24 (2025)

37. Halfmann PJ, Patel RS, Loeffler K, Yasuhara A, van de Velde L, Yang JE, Chervin J, Troxell C, Huang M, Zheng N, Wright ER, Thomas PG, Wilson PC, Kawaoka Y, Kane RS. Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice. Nature Communications. 16(1):462. https://doi.org/10.1038/s41467-025-55824-y (2025)

38. Higashi-Kuwata N, Bulut H, Hayashi H, Tsuji K, Ogata-Aoki H, Kiso M, Takamune N, Kishimoto N, Hattori S, Ishii T, Kobayakawa T, Nakano K, Shimizu Y, Das D, Saruwatari J, Hasegawa K, Murayama K, Sukenaga Y, Takamatsu Y, Yoshimura K, Aoki M, Furusawa Y, Okamura T, Yamayoshi S, Kawaoka Y, Misumi S, Tamamura H, Mitsuya H. An orally available P1'-5-fluorinated M(pro) inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier. PNAS Nexus. 4(1):pgae578. https://doi.org/10.1093/pnasnexus/pgae578 (2025)

39. Gu C, Babujee L, Pattinson D, Chiba S, Jester P, Maemura T, Neumann G, Kawaoka Y. Development of broadly protective influenza B vaccines. NPJ Vaccines. 10(1):2–w. https://doi.org/10.1038/s41541-024-01058-w (2025)

40. Tsutsui M, Tsunekawa Y, Wada M, Arima A, Onodera A, Nishina M, Nagoya M, Baba Y, Kawai T, Okada T. Enhanced Discriminability of Viral Vectors in Viscous Nanopores. Small methods. :e2401321. https://doi.org/10.1002/smtd.202401321 (2025) 

41. Alkhalaf LM, Arrowsmith C, Balskus EP, Bergamini G, Bhandari R, Chang CJ, Chen P, Chen X, Ciulli A, Cricco JA, Davis BG, Delbianco M, Dudareva N, Dueber E, Ferguson F, de Giuseppe PO, Hamachi I, Hammond MC, Hatzios SK, Do Heo W, Janet JP, Kamat SS, Knapp S, Krishnan Y, Lang K, Laraia L, Leveson-Gower RB, Li XD, Liu DR, Liu M, London N, Mahanta N, Mayor-Ruiz C, Muir T, Murakami MT, Rhee H, Robers M, Satz A, Schulman BA, Shen B, Shoichet B, Strauss E, Suzuki T, Tiwary P, Waldmann H, Ward TR, Weeks A, Weerapana E, Winter G. Thoughts for the future. Nat Chem Biol. 21(1):6–15. https://doi.org/10.1038/s41589-024-01802-2 (2025) 

42. Noji H, Minagawa Y, Ueno H. Digital bioassay. Oyo Buturi. 94(1):3–9. https://doi.org/10.11470/oubutsu.94.1_3 (2025)

2024

1. Ishizaka A*, Koga M, Mizutani T, Suzuki Y, Matano T, Yotsuyanagi H. Thiamine deficiency underlies persistent gut dysbiosis and inflammation in people living with HIV on antiretroviral therapy. Translational Medicine Communications. 9(1):25. https://doi.org/10.1186/s41231-024-00187-7 (2024) 

2. Nagamura R, Kujirai T, Kato J, Shuto Y, Kusakizako T, Hirano H, Endo M, Toki S, Saika H, Kurumizaka H, Nureki O. Structural insights into how Cas9 targets nucleosomes. Nat Commun. 15(1):10744–z. https://doi.org/10.1038/s41467-024-54768-z (2024)

3. Amano R, Takahashi M, Haga K, Yamamoto M, Goto K, Ichinose A, Hamada M, Gohda J, Inoue J, Kawaguchi Y, Moi ML, Nakamura Y. A chimeric RNA consisting of siRNA and aptamer for inhibiting dengue virus replication. NAR Mol Med. 1(4):ugae025. https://doi.org/10.1093/narmme/ugae025 (2024)
   論文解説　多機能キメラ核酸によるデングウイルス増殖抑制:  将来の感染症医薬開発へ幅広い応用の可能性

4. Katoh H, Kimura R, Sekizuka T, Matsuoka K, Hosogi M, Kitai Y, Akahori Y, Kato F, Kataoka M, Kobayashi H, Nagata N, Suzuki T, Ohkawa Y, Oki S, Takeda M. Structural and molecular properties of mumps virus inclusion bodies. Science Advances. 10(49):eadr0359. https://doi.org/10.1126/sciadv.adr0359 (2024)
   論文解説　グアニン四重鎖構造を持つRNAがおたふくかぜウイルスのRNA合成の場を提供する: ―おたふくかぜウイルスの封入体形成機構の理解―

5. Kim KQ, Li JJ, Nanjaraj Urs AN, Pacheco ME, Lasehinde V, Denk T, Tesina P, Tomomatsu S, Matsuo Y, McDonald E, Beckmann R, Inada T, Green R, Zaher HS. Multiprotein bridging factor 1 is required for robust activation of the integrated stress response on collided ribosomes. Mol Cell. 84(23):4594–4611.e9. https://doi.org/10.1016/j.molcel.2024.10.029 (2024)

6. Ay S, Burlaud-Gaillard J, Gazi A, Tatirovsky Y, Cuche C, Diana J, Scoca V, Di Santo JP, Roingeard P, Mammano F, Di Nunzio F. In vivo HIV-1 nuclear condensates safeguard against cGAS and license reverse transcription. EMBO J. 44(1):166–199. https://doi.org/10.1038/s44318-024-00316-w (2025)

7. Iijima N*, Yamaguchi M, Hayashi T, Rui Y, Ohira Y, Miyamoto Y, Niino M, Okuno T, Suzuki O, Oka M, Ishii KJ. miR-147-3p in pathogenic CD4 T cells controls chemokine receptor expression for the development of experimental autoimmune diseases. J Autoimmun. 149:103319. https://doi.org/10.1016/j.jaut.2024.103319 (2024)

8. Kaku Y, Okumura KAU-K, Kawakubo S, Uriu K, Chen L, Kosugi Y, Uwamino Y, Begum MM, Leong S, Ikeda T, Sadamasu K, Asakura H, Nagashima M, Yoshimura K, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Sato K. Virological characteristics of the SARS-CoV-2 XEC variant. Lancet Infect Dis. 24(12):e736–X. Epub 2024 Nov 6. https://doi.org/10.1016/S1473-3099(24)00731-X (2024)

9. Togashi T, Baatartsogt N, Nagao Y, Kashiwakura Y, Hayakawa M, Hiramoto T, Fujiwara T, Morishita E, Nureki O, Ohmori T. Cure of Congenital Purpura Fulminans via Expression of Engineered Protein C Through Neonatal Genome Editing in Mice. Arterioscler Thromb Vasc Biol. 44(12):2616–2627. https://doi.org/10.1161/ATVBAHA.123.319460 (2024)

10. Kobayashi M, Kobayashi N, Deguchi K, Omori S, Nagai M, Fukui R, Song I, Fukuda S, Miyake K, Ichinohe T. TNF-α exacerbates SARS-CoV-2 infection by stimulating CXCL1 production from macrophages. Plos Pathogens. 20(12):e1012776. https://doi.org/10.1371/journal.ppat.1012776 (2024)

11. Zhou NE, Tang S, Bian X, Parai MK, Krieger IV, Flores A, Jaiswal PK, Bam R, Wood JL, Shi Z, Stevens LJ, Scobey T, Diefenbacher MV, Moreira FR, Baric TJ, Acharya A, Shin J, Rathi MM, Wolff KC, Riva L, Bakowski MA, Mcnamara CW, Catanzaro NJ, Graham RL, Schultz DC, Cherry S, Kawaoka Y, Halfmann PJ, Baric RS, Denison MR, Sheahan TP, Sacchettini JC. An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo. Cell Reports. 43(11):114929. https://doi.org/10.1016/j.celrep.2024.114929 (2024)

12. Anzurez A, Runtuwene L, Dang TTT, Nakayama-Hosoya K, Koga M, Yoshimura Y, Sasaki H, Miyata N, Miyazaki K, Takahashi Y, Suzuki T, Yotsuyanagi H, Tachikawa N, Matano T, Kawana-Tachikawa A. Characterization of the Proinflammatory Cytokine Profile during Acute SARS-CoV-2 Infection in People with Human Immunodeficiency Virus. Jpn J Infect Dis. 77(6):301–310. https://doi.org/10.7883/yoken.JJID.2024.184 (2024)

13. Iwatsuki-Horimoto K, Kiso M, Ito M, Yamayoshi S, Kawaoka Y. Sensitivity of rodents to SARS-CoV-2: Gerbils are susceptible to SARS-CoV-2, but guinea pigs are not. npj Viruses. 2(1):59. https://doi.org/10.1038/s44298-024-00068-8 (2024) 

14. Kurata T, Takegawa M, Ohira T, Syroegin EA, Atkinson GC, Johansson MJO, Polikanov YS, Garcia-Pino A, Suzuki T, Hauryliuk V. Toxic small alarmone synthetase FaRel2 inhibits translation by pyrophosphorylating tRNA Gly and tRNA Thr. Science advances. 10(46):eadr9624. https://doi.org/10.1126/sciadv.adr9624 (2024) 

15. Ota A, Iguchi T, Nitta S, Muro R, Mino N, Tsukasaki M, Penninger JM, Nitta T, Takayanagi H. Synchronized development of thymic eosinophils and thymocytes. Int Immunol. 36(12):617–628. https://doi.org/10.1093/intimm/dxae037 (2024)

16. Tanaka R, Tamao K, Ono M, Yamayoshi S, Kawaoka Y, Su'etsugu M, Noji H, Tabata KV. In vitro one-pot construction of influenza viral genomes for virus particle synthesis based on reverse genetics system. PLoS One. 19(11):e0312776. https://doi.org/10.1371/journal.pone.0312776 (2024)

17. Akichika S, Suzuki T. Cap-specific m6Am modification: A transcriptional anti-terminator by sequestering PCF11 with implications for neuroblastoma therapy. Molecular cell. 84(21):4051–4052. https://doi.org/10.1016/j.molcel.2024.10.014 (2024) 

18. Oshima HS, Ogawa A, Sano FK, Akasaka H, Kawakami T, Iwama A, Okamoto HH, Nagiri C, Wei F, Shihoya W, Nureki O. Structural insights into the agonist selectivity of the adenosine A3 receptor. Nature Communications. 15(1):9294. https://doi.org/10.1038/s41467-024-53473-1 (2024)

19. Akasaka H, Sano FK, Shihoya W, Nureki O. Structural mechanisms of potent lysophosphatidic acid receptor 1 activation by nonlipid basic agonists. Commun Biol. 7(1):1444–y. https://doi.org/10.1038/s42003-024-07152-y (2024)

20. Chiba S, Kiso M, Yamada S, Someya K, Onodera Y, Yamaguchi A, Matsunaga S, Jounai N, Yamayoshi S, Takeshita F, Kawaoka Y. Protective effects of an mRNA vaccine candidate encoding H5HA clade 2.3.4.4b against the newly emerged dairy cattle H5N1 virus. eBioMedicine. 109:105408. https://doi.org/10.1016/j.ebiom.2024.105408 (2024) 

論文解説　高病原性鳥インフルエンザH5HAのLNP-mRNAワクチンは牛由来H5N1 ウイルスに対して防御効果を示す

21. Muro R, Nitta T, Nitta S, Tsukasaki M, Asano T, Nakano K, Okamura T, Nakashima T, Okamoto K, Takayanagi H. Transcript splicing optimizes the thymic self-antigen repertoire to suppress autoimmunity. J Clin Invest. 134(20):e179612. https://doi.org/10.1172/JCI179612 (2024)

22. Yajima H, Anraku Y, Kaku Y, Kimura KT, Plianchaisuk A, Okumura K, Nakada-Nakura Y, Atarashi Y, Hemmi T, Kuroda D, Takahashi Y, Kita S, Sasaki J, Sumita H, Ito J, Maenaka K, Sato K, Hashiguchi T. Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1. Nature Communications. 15(1):8574. https://doi.org/10.1038/s41467-024-52808-2 (2024)
    論文解説　新型コロナウイルス変異株の構造特性を解明 ―流行株の変化を原子レベルで可視化―

23. Gao P, Morita N, Shinkura R. Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers. Semin Immunopathol. 47(1):1–4. https://doi.org/10.1007/s00281-024-01027-4 (2024)

24. Shimoyama M, Nakada-Tsukui K, Nozaki T. EhRacM differentially regulates macropinocytosis and motility in the enteric protozoan parasite Entamoeba histolytica. PLoS Pathog. 20(11):e1012364. https://doi.org/10.1371/journal.ppat.1012364 (2024)

25. Kawataki S, Kubota Y, Katayama K, Imoto S, Takekawa M. GADD45beta-MTK1 signaling axis mediates oncogenic stress-induced activation of the p38 and JNK pathways. Cancer Sci. https://doi.org/10.1111/cas.16389 (2024)

26. Umegaki T, Moriizumi H, Ogushi F, Takekawa M, Suzuki T. Molecular dynamics simulations of a multicellular model with cell-cell interactions and Hippo signaling pathway. PLoS computational biology. 20(11):e1012536. https://doi.org/10.1371/journal.pcbi.1012536 (2024)  

27. Kuwata T, Kaku Y, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, Uraki R, Okazaki K, Minami R, Nagasaki Y, Nagashima M, Yoshida I, Sadamasu K, Yoshimura K, Ito M, Kiso M, Yamayoshi S, Imai M, Ikeda T, Sato K, Toyoda M, Ueno T, Inoue T, Tanaka Y, Kimura KT, Hashiguchi T, Sugita Y, Noda T, Morioka H, Kawaoka Y, Matsushita S, Genotype to Phenotype Japan (G2P-Japan) Consortium. Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case. EBioMedicine. 110:105439. https://doi.org/10.1016/j.ebiom.2024.105439 (2024)

28. Ueda T, Adachi T, Hayashi T, Yasuda K, Matsushita K, Koike E, Yanagisawa R, Nagatake T, Kunisawa J, Ishii KJ, Tsuzuki K, Kuroda E. Bisphenol A triggers activation of ocular immune system and aggravates allergic airway inflammation. Clin Immunol. 268:110370. https://doi.org/10.1016/j.clim.2024.110370 (2024)

29. Gu C, Maemura T, Guan L, Eisfeld AJ, Biswas A, Kiso M, Uraki R, Ito M, Trifkovic S, Wang T, Babujee L, Presler RJ, Dahn R, Suzuki Y, Halfmann PJ, Yamayoshi S, Neumann G, Kawaoka Y. A human isolate of bovine H5N1 is transmissible and lethal in animal models. Nature.  636(8043)  https://doi.org/10.1038/s41586-024-08254-7 (2024)

論文解説　ヒトから分離された牛由来高病原性H5N1鳥インフルエンザウイルスの病原性と感染伝播性

30. Hoxie I, Vasilev K, Clark JJ, Bushfield K, Francis B, Loganathan M, Campbell JD, Yu D, Guan L, Gu C, Fan S, Tompkins SM, Neumann G, Kawaoka Y, Krammer F. A recombinant N2 neuraminidase-based CpG 1018(R) adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters. Vaccine. 42(24):126269. https://doi.org/10.1016/j.vaccine.2024.126269 (2024)

31. Maharjan S, Gamper H, Yamaki Y, Christian T, Henley RY, Li N, Suzuki T, Suzuki T, Piccirilli JA, Wanunu M, Seifert E, Wallace DC, Hou Y. Post-transcriptional methylation of mitochondrial-tRNA differentially contributes to mitochondrial pathology. Nat Commun. 15(1):9008–17. https://doi.org/10.1038/s41467-024-53318-x (2024) 

32. Yajima H, Nomai T, Okumura K, Maenaka K, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Hashiguchi T, Sato K. Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants. mBio. 15(10):e0322023–23. Epub 2024 Sep 16. https://doi.org/10.1128/mbio.03220-23 (2024)

33. Chiba S, Kiso M, Yamada S, Someya K, Onodera Y, Yamaguchi A, Matsunaga S, Uraki R, Iwatsuki-Horimoto K, Yamayoshi S, Takeshita F, Kawaoka Y. An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infection. NPJ Vaccines. 9(1):189–9. https://doi.org/10.1038/s41541-024-00988-9 (2024)

34. Yaku H, Takahashi K, Okada H, Kobiyama K, Shiokawa M, Uza N, Kodama Y, Ishii KJ, Seno H. Near-infrared photoimmunotherapy as a complementary modality to in situ vaccine in a preclinical pancreatic cancer model. Biochem Biophys Res Commun. 737:150534. https://doi.org/10.1016/j.bbrc.2024.150534 (2024)

35. Jiang H, Santos HJ, Nozaki T. Tetraspanin-enriched microdomains play an important role in pathogenesis in the protozoan parasite Entamoeba histolytica. PLoS Pathog. 20(10):e1012151. https://doi.org/10.1371/journal.ppat.1012151 (2024)

36. Matsuura J, Akichika S, Wei F, Suzuki T, Yamamoto T, Watanabe Y, Valášek LS, Mukasa A, Tomizawa K, Chujo T. Human DUS1L catalyzes dihydrouridine modification at tRNA positions 16/17, and DUS1L overexpression perturbs translation. Commun Biol. 7(1):1238–12. https://doi.org/10.1038/s42003-024-06942-8 (2024) 

37. Arango-Franco C, Ogishi M, Unger S, Delmonte OM, Orrego JC, Yatim A, Velasquez-Lopera M, Zea-Vera A, Bohlen J, Chbihi M, Fayand A, Sanchez JP, Rojas J, Seeleuthner Y, Le Voyer T, Philippot Q, Payne KJ, Gervais A, Erazo-Borras L, Correa-Londono L, Cederholm A, Gallon-Duque A, Goncalves P, Doisne J, Horev L, Charmeteau-de Muylder B, Alvarez JA, Arboleda DM, Perez-Zapata L, Vasquez-Echeverri E, Moncada-Velez M, Lopez JA, Caicedo Y, Palterer B, Patino PJ, Montoya CJ, Chaldebas M, Zhang P, Nguyen T, Ma CS, Jeljeli M, Alzate JF, Cabarcas F, Khan T, Rinchai D, Pretet J, Boisson B, Generalized Verrucosis JC, Marr N, Ibrahim R, Molho-Pessach V, Boisson-Dupuis S, Kiritsi D, Barata JT, Landegren N, Neven B, Abel L, Lisco A, Beziat V, Jouanguy E, Bustamante J, Di Santo JP, Tangye SG, Notarangelo LD, Cheynier R, Natsuga K, Arias AA, Franco JL, Warnatz K, Casanova J, Puel A. IL-7-dependent and -independent lineages of IL-7R-dependent human T cells. J Clin Invest. 134(19):e180251. doi: 10.1172/JCI180251. https://doi.org/10.1172/JCI180251 (2024)

38. Eiden J, Fierro C, White A, Davis M, Rhee M, Turner M, Murray B, Herber R, Aitchison R, Marshall D, Moser MJ, Belshe R, Greenberg H, Coelingh K, Kawaoka Y, Neumann G, Bilsel P. Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial. Lancet Infect Dis. 24(10):1118–7 pii]. https://doi.org/10.1016/S1473-3099(24)00351-7 (2024)

39. Kaku Y, Uriu K, Okumura K, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Sato K. Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant. Lancet Infect Dis. 24(10):e609–X. Epub 2024 Aug 16. https://doi.org/10.1016/S1473-3099(24)00505-X (2024a)

40. Nakamura K, Tsukasaki M, Tsunematsu T, Yan M, Ando Y, Huynh NC, Hashimoto K, Gou Q, Muro R, Itabashi A, Iguchi T, Okamoto K, Nakamura T, Nakano K, Okamura T, Ueno T, Ito K, Ishimaru N, Hoshi K, Takayanagi H. The periosteum provides a stromal defence against cancer invasion into the bone. Nature. 634(8033):474–481. https://doi.org/10.1038/s41586-024-07822-1 (2024)

41. Kaku Y, Okumura KA-K, Kawakubo S, Uriu K, Chen L, Kosugi Y, Uwamino Y, Begum MM, Leong S, Ikeda T, Sadamasu K, Asakura H, Nagashima M, Yoshimura K, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Sato K. Virological characteristics of the SARS-CoV-2 XEC variant. Lancet Infect Dis. 24(12):e736–X. Epub 2024 Nov 6. https://doi.org/10.1016/S1473-3099(24)00731-X (2024)
    論文解説　SARS-CoV-2オミクロンXEC株のウイルス学的特性の解明

42. Wulansari D, Jeelani G, Yazaki E, Nozaki T. Identification and characterization of archaeal-type FAD synthase as a novel tractable drug target from the parasitic protozoa Entamoeba histolytica. mSphere. 9(9):e0034724–24. Epub 2024 Aug 27. https://doi.org/10.1128/msphere.00347-24 (2024)

43. Kiso M, Uraki R, Yamayoshi S, Imai M, Kawaoka Y. Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals. Iscience. 27(9):110729. https://doi.org/10.1016/j.isci.2024.110729 (2024)

44. Miyauchi K, Kimura S, Akiyama N, Inoue K, Ishiguro K, Vu T, Srisuknimit V, Koyama K, Hayashi G, Soma A, Nagao A, Shirouzu M, Okamoto A, Waldor MK, Suzuki T. A tRNA modification with aminovaleramide facilitates AUA decoding in protein synthesis. Nat Chem Biol. https://doi.org/10.1038/s41589-024-01726-x (2024)

45. Tanaka T, Hososhima S, Yamashita Y, Sugimoto T, Nakamura T, Shigemura S, Iida W, Sano FK, Oda K, Uchihashi T, Katayama K, Furutani Y, Tsunoda SP, Shihoya W, Kandori H, Nureki O. The high-light-sensitivity mechanism and optogenetic properties of the bacteriorhodopsin-like channelrhodopsin GtCCR4. Mol Cell. 84(18) https://doi.org/10.1016/j.molcel.2024.08.016 (2024)

46. Omura SN, Nureki O. Exploring RNA-guided DNA scissors in eukaryotes: Are Fanzors counterparts of CRISPR-Cas12s? Cell. 187(19):5220–5222. https://doi.org/10.1016/j.cell.2024.08.022 (2024)

47. Muraoka D, Moi ML, Muto O, Nakatsukasa T, Deng S, Takashima C, Yamaguchi R, Sawada S, Hayakawa H, Nguyen TTN, Haseda Y, Soga T, Matsushita H, Ikeda H, Akiyoshi K, Harada N. Low-frequency CD8(+) T cells induced by SIGN-R1(+) macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice. NPJ Vaccines. 9(1):173–6. https://doi.org/10.1038/s41541-024-00961-6 (2024)

論文解説　我が国独自のナノ粒子性薬剤送達システムを用いた次世代ワクチンの新型コロナウイルスに対する優れたキラーT細胞誘導と感染防御性能を動物モデルで実証

48. Hattori S, Bulut H, Hayashi H, Kishimoto N, Takamune N, Hasegawa K, Furusawa Y, Yamayoshi S, Murayama K, Tamamura H, Li M, Wlodawer A, Kawaoka Y, Misumi S, Mitsuya H. Structural and virologic mechanism of the emergence of resistance to M(pro) inhibitors in SARS-CoV-2. Proc Natl Acad Sci U S A. 121(37):e2404175121. https://doi.org/10.1073/pnas.2404175121 (2024)

49. Ishibashi K, Sukegawa S, Endo M, Hara N, Nureki O, Saika H, Toki S. Systemic delivery of engineered compact AsCas12f by a positive-strand RNA virus vector enables highly efficient targeted mutagenesis in plants. Front Plant Sci. 15:1454554. https://doi.org/10.3389/fpls.2024.1454554 (2024)

50. Takahashi K, Morita N, Tamano R, Gao P, Iida N, Andoh A, Imaeda H, Kurokawa K, Tsuboi M, Hayakawa Y, Fujishiro M, Shinkura R. Mouse IgA modulates human gut microbiota with inflammatory bowel disease patients. J Gastroenterol. 59(9):812–824. https://doi.org/10.1007/s00535-024-02121-y (2024)

51. Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay AA,Jr, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K, Genotype to Phenotype Japan (G2P-Japan) Consortium. Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant. Microbiol Immunol. 68(9):305–330. https://doi.org/10.1111/1348-0421.13165 (2024)

52. Chiba S, Maemura T, Loeffler K, Frey SJ, Gu C, Biswas A, Hatta M, Kawaoka Y, Kane RS. Single immunization with an influenza hemagglutinin nanoparticle-based vaccine elicits durable protective immunity. Bioengineering & Translational Medicine. https://doi.org/10.1002/btm2.10689 (2024)

53. Inoue T, Baba Y, Kurosaki T. BCR signaling in germinal center B cell selection. Trends Immunol. 45(9):693–704. https://doi.org/10.1016/j.it.2024.07.005 (2024)

54. Neumann G, Kawaoka Y. Highly pathogenic H5N1 avian influenza virus outbreak in cattle: the knowns and unknowns. Nature Reviews Microbiology. 22(9):525–526. https://doi.org/10.1038/s41579-024-01087-1 (2024)

55. Takashita E, Ichikawa M, Fujisaki S, Morita H, Nagata S, Miura H, Watanabe S, Hasegawa H, Kawaoka Y. Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infecte d pe diatric patients. International Journal of Infectious Diseases. 146:107134. https://doi.org/10.1016/j.ijid.2024.107134 (2024)

56. Liu S, Maruzuru Y, Takeshima K, Koyanagi N, Kato A, Kawaguchi Y. Impact of the interaction between herpes simplex virus 1 ICP22 and FACT on viral gene expression and pathogenesis. J Virol. 98(8):e0073724–24. Epub 2024 Jul 17. https://doi.org/10.1128/jvi.00737-24 (2024)

57. Akasaka H, Sato D, Shihoya W, Nureki O, Kise Y. Cryo-EM structure of I domain-containing integrin alphaEbeta7. Biochem Biophys Res Commun. 721:150121. https://doi.org/10.1016/j.bbrc.2024.150121 (2024)

58. Alshaweesh J, Dash R, Lee MSJ, Kahyaoglu P, Erci E, Xu M, Matsuo-Dapaah J, Del Rosario Zorrilla C, Aykac K, Ekemen S, Kobiyama K, Ishii KJ, Coban C. MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malaria. Int Immunol. 36(9):451–464. https://doi.org/10.1093/intimm/dxae023 (2024)

59. Sekine W, Kamiki H, Ishida H, Matsugo H, Ohira K, Li K, Katayama M, Takenaka-Uema A, Murakami S, Horimoto T. Adaptation potential of H3N8 canine influenza virus in human respiratory cells. Sci Rep. 14(1):18750–11. https://doi.org/10.1038/s41598-024-69509-x (2024) 

60. Manabe S, Iwamoto S, Nagatoishi S, Hoshinoo A, Mitani A, Sumiyoshi W, Kinoshita T, Yamaguchi Y, Tsumoto K. Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation. J Am Chem Soc. 146(33):23426–23436. https://doi.org/10.1021/jacs.4c06558 (2024)

61. Kaku Y, Yo M, Tolentino JE, Uriu K, Okumura K, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Sato K. Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants. Lancet Infect Dis. 24(8):e482–e483. https://doi.org/10.1016/S1473-3099(24)00415-8 (2024)

62. Mizutani T, Ishizaka A*. Poliovirus capsid protein VP3 can penetrate vascular endothelial cells. FEBS Lett. 598(15):1909–1918. https://doi.org/10.1002/1873-3468.14974 (2024)

63. Huynh NC, Ling R, Komagamine M, Shi T, Tsukasaki M, Matsuda K, Okamoto K, Asano T, Muro R, Pluemsakunthai W, Kollias G, Kaneko Y, Takeuchi T, Tanaka S, Komatsu N, Takayanagi H. Oncostatin M-driven macrophage-fibroblast circuits as a drug target in autoimmune arthritis. Inflamm Regen. 44(1):36-0. https://doi.org/10.1186/s41232-024-00347-0 (2024)

64. Ishizaka A, Koga M, Mizutani T, Suzuki Y, Matano T, Yotsuyanagi H. Sustained gut dysbiosis and intestinal inflammation show correlation with weight gain in person with chronic HIV infection on antiretroviral therapy. BMC Microbiol. 24(1):274-0. https://doi.org/10.1186/s12866-024-03431-0 (2024)

65. Kato A, Iwasaki R, Takeshima K, Maruzuru Y, Koyanagi N, Natsume T, Kusano H, Adachi S, Kawano S, Kawaguchi Y. Identification of a novel neurovirulence factor encoded by the cryptic orphan gene UL31.6 of herpes simplex virus 1. J Virol. 98(7):e0074724-24. Epub 2024 May 31. https://doi.org/10.1128/jvi.00747-24 (2024)

66. Iijima N, Hayashi T, Niino M, Miyamoto Y, Oka M, Ishii KJ. Tridecylcyclohexane in incomplete Freund's adjuvant is a critical component in inducing experimental autoimmune diseases. Eur J Immunol. :e2350957. https://doi.org/10.1002/eji.202350957 (2024)

67. Eisfeld AJ, Biswas A, Guan L, Gu C, Maemura T, Trifkovic S, Wang T, Babujee L, Dahn R, Halfmann PJ, Barnhardt T, Neumann G, Suzuki Y, Thompson A, Swinford AK, Dimitrov KM, Poulsen K, Kawaoka Y. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature. https://doi.org/10.1038/s41586-024-07766-6 (2024)

論文解説　牛由来高病原性H5N1鳥インフルエンザウイルスの マウスおよびフェレットにおける病原性と伝播性

68. Guan L, Eisfeld AJ, Pattinson D-PD, Gu C, Biswas A, Maemura T, Trifkovic S, Babujee L, Presler RJ, Dahn R, Halfmann PJ, Barnhardt T, Neumann G, Thompson A, Swinford AK, Dimitrov KM, Poulsen K, Kawaoka Y. Cow's Milk Containing Avian Influenza A(H5N1) Virus - Heat Inactivation and Infectivity in Mice. N Engl J Med. 391(1):87-90. https://doi.org/10.1056/NEJMc2405495 (2024)

論文解説　牛乳から検出された高病原性H5N1鳥インフルエンザウイルスの熱不活性化とマウスへの感染性

69. Nakane T, Nakagawa R, Ishiguro S, Okazaki S, Mori H, Shuto Y, Yamashita K, Yachie N, Nishimasu H, Nureki O. Structure and engineering of Brevibacillus laterosporus Cas9. Commun Biol. 7(1):803-z. https://doi.org/10.1038/s42003-024-06422-z (2024)

70. Inoue T, Matsumoto Y, Kawai C, Ito M, Nada S, Okada M, Kurosaki T. Csk restrains BCR-mediated ROS production and contributes to germinal center selection and affinity maturation. J Exp Med. 221(7):e20231996. doi: 10.1084/jem.20231996. Epub 2024 May 16. https://doi.org/10.1084/jem.20231996 (2024)

論文解説　B細胞が適切に選択される仕組みを解明　―抗体の親和性成熟を導く胚中心のメカニズム―

71. Shuto Y, Nakagawa R, Zhu S, Hoki M, Omura SN, Hirano H, Itoh Y, Zhang F, Nureki O. Structural basis for pegRNA-guided reverse transcription by a prime editor. Nature. 631(8019):224–231. https://doi.org/10.1038/s41586-024-07497-8 (2024)

72. Kaku Y, Uriu K, Kosugi Y, Okumura K, Yamasoba D, Uwamino Y, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Sato K. Virological characteristics of the SARS-CoV-2 KP.2 variant. Lancet Infect Dis. 24(7):e416–6. Epub 2024 May 20. https://doi.org/10.1016/S1473-3099(24)00298-6 (2024)

73. Asano R, Nakakido M, Perez JF, Ise T, Caaveiro JMM, Nagata S, Tsumoto K. Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumab. Biochem Biophys Res Commun. 714:149969. https://doi.org/10.1016/j.bbrc.2024.149969 (2024)

74. Iwama A, Kise R, Akasaka H, Sano FK, Oshima HS, Inoue A, Shihoya W, Nureki O. Structure and dynamics of the pyroglutamylated RF-amide peptide QRFP receptor GPR103. Nat Commun. 15(1):4769-5. https://doi.org/10.1038/s41467-024-49030-5 (2024)

75. Tsutsui M, Wada M, Arima A, Tsunekawa Y, Sasaki T, Sakamoto K, Yokota K, Baba Y, Kawai T, Okada T. Identifying Viral Vector Characteristics by Nanopore Sensing. ACS nano. 18(24):15695–15704. https://doi.org/10.1021/acsnano.4c01888 (2024) 

76. Petrie JG, Pattinson D, King JP, Neumann G, Guan L, Jester P, Rolfes MA, Meece JK, Kieke BA, Belongia EA, Kawaoka Y, Nguyen HQ. SARS-CoV-2 incidence, seroprevalence, and antibody dynamics in a rural, population-based cohort: March 2020 - July 2022. Am J Epidemiol. https://doi.org/10.1093/aje/kwae125 (2024)

77. Lee MSJ, Matsuo-Dapaah J, Del Rosario Zorrilla C, Omatsu Y, Nagasawa T, Uemura S, Iwama A, Ishii KJ, Coban C. Acute malaria suppresses the B lymphocytic niche in the bone marrow through the alteration of CXCL12-abundant reticular cells. Int Immunol. 36(7):339–352. https://doi.org/10.1093/intimm/dxae012 (2024)

78. Fujita S, Plianchaisuk A, Deguchi S, Ito H, Nao N, Wang L, Nasser H, Tamura T, Kimura I, Kashima Y, Suzuki R, Suzuki S, Kida I, Tsuda M, Oda Y, Hashimoto R, Watanabe Y, Uriu K, Yamasoba D, Guo Z, Hinay AAJ, Kosugi Y, Chen L, Pan L, Kaku Y, Chu H, Donati F, Temmam S, Eloit M, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Suzuki Y, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Ikeda T, Tanaka S, Matsuno K, Fukuhara T, Takayama K, Sato K. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236. EBioMedicine. 104:105181. https://doi.org/10.1016/j.ebiom.2024.105181 (2024)

79. Ito S, Matsunaga R, Nakakido M, Komura D, Katoh H, Ishikawa S, Tsumoto K. High-throughput system for the thermostability analysis of proteins. Protein Sci. 33(6):e5029. https://doi.org/10.1002/pro.5029 (2024)

80. Shimizu K, Kawakami C, Matsuzaki Y, Fujisaki S, Nagata S, Morita H, Watanabe K, Miura H, Momoki T, Saikusa M, Ozawa H, Kumazaki M, Usuku S, Tanaka N, Senda R, Okubo I, Watanabe S, Hasegawa H, Kawaoka Y, Takashita E. Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023. Influenza Other Respir Viruses. 18(6):e13345. https://doi.org/10.1111/irv.13345 (2024)

81. Kurosawa Y, Tsunekawa Y, Wada M, Aizen Y, Nitahara‐Kasahara Y, Okada T. Purification of Adeno‐Associated Viral Vector Serotype 9 Using Ceramic Hydroxyapatite Chromatography and its Analysis. Current protocols. 4(6):e1068–n/a. https://doi.org/10.1002/cpz1.1068 (2024) 

82. Tang Y, Feng X, Lu Q, Cui C, Yu M, Wen Z, Luan Y, Dong L, Hu Z, Zhang R, Lu C, Liu J, Shinkura R, Hase K, Wang J. MZB1-mediated IgA secretion suppresses the development and progression of colorectal cancer triggered by gut inflammation. Mucosal immunology. 17(3):450–460. https://doi.org/10.1016/j.mucimm.2023.12.002 (2024) 

83. Yoshioka D, Nakamura T, Kubota Y, Takekawa M. Formation of the NLRP3 inflammasome inhibits stress granule assembly by multiple mechanisms. J Biochem. 175(6):629-641. https://doi.org/10.1093/jb/mvae009 (2024)

84. Setoguchi R, Sengiku T, Kono H, Kawakami E, Kubo M, Yamamoto T, Hori S. Memory CD8 T cells are vulnerable to chronic IFN-γ  signals but not to CD4 T cell deficiency in MHCII-deficient mice. Nat Commun. 15(1):4418-4. https://doi.org/10.1038/s41467-024-48704-4 (2024)

論文解説　免疫記憶を担うメモリーCD8 T細胞の恒常性維持機構を解明　―持続的IFN-ɤシグナルは免疫記憶を弱体化する―

85. Kitai Y, Watanabe O, Ohmiya S, Kisu T, Ota R, Kawakami K, Katoh H, Fukuzawa K, Takeda M, Nishimura H. Detailed analysis of low temperature inactivation of respiratory syncytial virus. Sci Rep. 14(1):11823-z. https://doi.org/10.1038/s41598-024-62658-z (2024)

86. Yamamoto K, Nagatoishi S, Nakakido M, Kuroda D, Tsumoto K. Functional insights of Tyr37 in framework region 2 directly contributing to the binding affinities and dissociation kinetics in single-domain V H H antibodies. Biochem Biophys Res Commun. 709:149839. https://doi.org/10.1016/j.bbrc.2024.149839 (2024)

87. Muehlemann B, Wilks SH, Baracco L, Bekliz M, Carreno JM, Corman VM, Davis-Gardner ME, Dejnirattisai W, Diamond MS, Douek DC, Drosten C, Eckerle I, Edara V, Ellis M, Fouchier RAM, Frieman M, Godbole S, Haagmans B, Halfmann PJ, Henry AR, Jones TC, Katzelnick LC, Kawaoka Y, Kimpel J, Krammer F, Lai L, Liu C, Lusvarghi S, Meyer B, Mongkolsapaya J, Montefiori DC, Mykytyn A, Netzl A, Pollett S, Roessler A, Screaton GR, Shen X, Sigal A, Simon V, Subramanian R, Supasa P, Suthar MS, Tuereli S, Wang W, Weiss CD, Smith DJ. Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays. Science Translational Medicine. 16(747):eadl1722. https://doi.org/10.1126/scitranslmed.adl1722 (2024)

88. Pattinson D, Jester P, Gu C, Guan L, Armbrust T, Petrie JG, King JP, Nguyen HQ, Belongia EA, Halfmann P, Neumann G, Kawaoka Y. Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses. EBioMedicine. 103:105103. https://doi.org/10.1016/j.ebiom.2024.105103 (2024)

89. Wang W, Harimurti S, Inoue D, Nayeem MOG, Wang J, Okuda C, Hashizume D, Lee S, Fukuda K, Yokota T, Someya T. Janus Membrane-Based Wearable pH Sensor with Sweat Absorption, Gas Permeability, and Self-Adhesiveness. Acs Applied Materials & Interfaces. 16(21):27065–27074. https://doi.org/10.1021/acsami.4c02189 (2024)

90. Fujii M, Ito S, Katsumata E, Chambers JK, Matsugo H, Takenaka-Uema A, Murakami S, Uchida K, Horimoto T. Japanese Encephalitis Virus and Schizophyllum commune Co-Infection in a Harbor Seal in Japan. Veterinary sciences. 11(5):215. https://doi.org/10.3390/vetsci11050215 (2024) 

91. Akiyama N, Ishiguro K, Yokoyama T, Miyauchi K, Nagao A, Shirouzu M, Suzuki T. Structural insights into the decoding capability of isoleucine tRNAs with lysidine and agmatidine. Nature Structural & Molecular Biology. 31(5) https://doi.org/10.1038/s41594-024-01238-1 (2024)

92. Sasaki I, Fukuda-Ohta Y, Nakai C, Wakaki-Nishiyama N, Okamoto C, Okuzaki D, Morita S, Kaji S, Furuta Y, Hemmi H, Kato T, Yamamoto A, Tosuji E, Saitoh S, Tanaka T, Hoshino K, Fukuda S, Miyake K, Kuroda E, Ishii KJ, Iwawaki T, Furukawa K, Kaisho T. A stress sensor, IRE1α, is required for bacterial-exotoxin-induced interleukin-1β production in tissue-resident macrophages. Cell Rep. 43(4):113981. https://doi.org/10.1016/j.celrep.2024.113981 (2024)

93. Hill-Batorski L, Bowen R, Bielefeldt-Ohmann H, Moser MJ, Matejka SM, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge. Vaccine. 42(11):2770–2780. https://doi.org/10.1016/j.vaccine.2024.03.040 (2024)

94. Tolentino JE, Lytras S, Ito J, Sato K. Recombination analysis on the receptor switching event of MERS-CoV and its close relatives: implications for the emergence of MERS-CoV. Virol J. 21(1):84-2. https://doi.org/10.1186/s12985-024-02358-2 (2024)

95. Eisfeld AJ, Anderson LN, Fan S, Walters KB, Halfmann PJ, Westhoff Smith D, Thackray LB, Tan Q, Sims AC, Menachery VD, Schafer A, Sheahan TP, Cockrell AS, Stratton KG, Webb-Robertson B, Kyle JE, Burnum-Johnson K, Kim Y, Nicora CD, Peralta Z, N'jai AU, Sahr F, van Bakel H, Diamond MS, Baric RS, Metz TO, Smith RD, Kawaoka Y, Waters KM. A compendium of multi-omics data illuminating host responses to lethal human virus infections. Sci Data. 11(1):328–3. https://doi.org/10.1038/s41597-024-03124-3 (2024)

96. Shafer MM, Bobholz MJ, Vuyk WC, Gregory DA, Roguet A, Haddock Soto LA, Rushford C, Janssen KH, Emmen IE, Ries HJ, Pilch HE, Mullen PA, Fahney RB, Wei W, Lambert M, Wenzel J, Halfmann P, Kawaoka Y, Wilson NA, Friedrich TC, Pray IW, Westergaard R, O'Connor DH, Johnson MC. Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage. Lancet Microbe. 5(4):e335–e344. https://doi.org/10.1016/S2666-5247(23)00372-5 (2024)

97. Goto M, Takahashi H, Yoshida R, Itamiya T, Nakano M, Nagafuchi Y, Harada H, Shimizu T, Maeda M, Kubota A, Toda T, Hatano H, Sugimori Y, Kawahata K, Yamamoto K, Shoda H, Ishigaki K, Ota M, Okamura T, Fujio K. Age-associated CD4(+) T cells with B cell-promoting functions are regulated by ZEB2 in autoimmunity. Sci Immunol. 9(93):eadk1643. https://doi.org/10.1126/sciimmunol.adk1643 (2024)

論文解説　自己免疫疾患の制御に関わる新たな加齢関連T細胞を発見

98. Onishi S, Uchiyama K, Sato K, Okada C, Kobayashi S, Hamada K, Nishizawa T, Nureki O, Ogata K, Sengoku T. Structure of the human Bre1 complex bound to the nucleosome. Nat Commun. 15(1):2580-8. https://doi.org/10.1038/s41467-024-46910-8 (2024)

99. Katayama M, Murakami S, Ishida H, Matsugo H, Sekine W, Ohira K, Takenaka-Uema A, Horimoto T. Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein among influenza D virus lineages revealed using epitope mapping. J Virol. 98(3):e0190823-23. Epub 2024 Feb 12. https://doi.org/10.1128/jvi.01908-23 (2024)

100. Shihoya W, Iwama A, Sano FK, Nureki O. Cryo-EM advances in GPCR structure determination. J Biochem. https://doi.org/10.1093/jb/mvae029 (2024)

101. Serafini N, Di Santo JP. Group 3 innate lymphoid cells: A trained Gutkeeper. Immunol Rev. https://doi.org/10.1111/imr.13322 (2024)

102. Watanabe S, Kise Y, Yonezawa K, Inoue M, Shimizu N, Nureki O, Inaba K. Structure of full-length ERGIC-53 in complex with MCFD2 for cargo transport. Nat Commun. 15(1):2404-1. https://doi.org/10.1038/s41467-024-46747-1 (2024)

103. Halfmann PJ, Iwatsuki-Horimoto K, Kuroda M, Hirata Y, Yamayoshi S, Iida S, Uraki R, Ito M, Ueki H, Furusawa Y, Sakai-Tagawa Y, Kiso M, Armbrust T, Spyra S, Maeda K, Wang Z, Imai M, Suzuki T, Kawaoka Y. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters. Commun Biol. 7(1):331-w. https://doi.org/10.1038/s42003-024-06015-w (2024)

104. Inada T, Beckmann R. Mechanisms of Translation-coupled Quality Control. J Mol Biol. 436(6):168496. https://doi.org/10.1016/j.jmb.2024.168496 (2024)

105. Song I, Yang J, Saito M, Hartanto T, Nakayama Y, Ichinohe T, Fukuda S. Prebiotic inulin ameliorates SARS-CoV-2 infection in hamsters by modulating the gut microbiome. NPJ Sci Food. 8(1):18-z. https://doi.org/10.1038/s41538-024-00248-z (2024)

106. Begum MSTM, Ichihara K, Takahashi O, Nasser H, Jonathan M, Tokunaga K, Yoshida I, Nagashima M, Sadamasu K, Yoshimura K, Sato K, Ikeda T, Genotype Phenotype Japan G2P Japan. Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity. Frontiers in Virology. 4:1353661. https://doi.org/10.3389/fviro.2024.1353661 (2024)

107. Temizoz B, Shibahara T, Hioki K, Hayashi T, Kobiyama K, Lee MSJ, Surucu N, Sag E, Kumanogoh A, Yamamoto M, Gursel M, Ozen S, Kuroda E, Coban C, Ishii KJ. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation. Front Immunol. 15:1353336. https://doi.org/10.3389/fimmu.2024.1353336 (2024)

108. Hiranuma R, Sato R, Yamaguchi K, Nakamizo S, Asano K, Shibata T, Fukui R, Furukawa Y, Kabashima K, Miyake K. Aberrant monocytopoiesis drives granuloma development in sarcoidosis. Int Immunol. 36(4):183-196. https://doi.org/10.1093/intimm/dxad054 (2024)

109. Guo Z, Murakami M, Saito K, Kato H, Toriyama M, Tominaga M, Ishii KJ, Fujita F. Integrin alpha5 regulates motility of human monocyte-derived Langerhans cells during immune response. Exp Dermatol. 33(3):e15021. https://doi.org/10.1111/exd.15021 (2024)

110. Kosugi Y, Kaku Y, Hinay AAJ, Guo Z, Uriu K, Kihara M, Saito F, Uwamino Y, Kuramochi J, Shirakawa K, Takaori-Kondo A, Genotype to Phenotype Japan (G2P-Japan) Consortium, Sato K. Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals. Lancet Infect Dis. 24(3):e147-e148. https://doi.org/10.1016/S1473-3099(23)00784-3 (2024)

論文解説　オミクロンXBB.1.5株対応1価ワクチンにより誘導されるオミクロン亜株に対する液性免疫の効果

111. Jo-Watanabe A, Inaba T, Osada T, Hashimoto R, Nishizawa T, Okuno T, Ihara S, Touhara K, Hattori N, Oh-Hora M, Nureki O, Yokomizo T. Bicarbonate signalling via G protein-coupled receptor regulates ischaemia-reperfusion injury. Nat Commun. 15(1):1530-3. https://doi.org/10.1038/s41467-024-45579-3 (2024)

112. Ando Y, Tsukasaki M, Huynh NC, Zang S, Yan M, Muro R, Nakamura K, Komagamine M, Komatsu N, Okamoto K, Nakano K, Okamura T, Yamaguchi A, Ishihara K, Takayanagi H. The neutrophil-osteogenic cell axis promotes bone destruction in periodontitis. Int J Oral Sci. 16(1):18-8. https://doi.org/10.1038/s41368-023-00275-8 (2024)

113. Gu C, Fan S, Dahn R, Babujee L, Chiba S, Guan L, Maemura T, Pattinson D, Neumann G, Kawaoka Y. Characterization of a human H3N8 influenza virus. EBioMedicine. 101:105034. https://doi.org/10.1016/j.ebiom.2024.105034 (2024)

114. Nobe M, Maruzuru Y, Takeshima K, Koyanagi N, Kato A, Kawaguchi Y. MYBBP1A is required for efficient replication and gene expression of herpes simplex virus 1. Microbiol Immunol. https://doi.org/10.1111/1348-0421.13120 (2024)

115. Fan S, Kong H, Babujee L, Presler R,Jr, Jester P, Burke D, Pattinson D, Barr I, Smith D, Neumann G, Kawaoka Y. Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera. EBioMedicine. 101:105013. https://doi.org/10.1016/j.ebiom.2024.105013 (2024)

116. Tamura T, Mizuma K, Nasser H, Deguchi S, Padilla-Blanco M, Oda Y, Uriu K, Tolentino JEM, Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Wang L, Tsuda M, Jonathan M, Kosugi Y, Guo Z, Hinay AAJ, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Ito J, Irie T, Tanaka S, Zahradnik J, Ikeda T, Takayama K, Matsuno K, Fukuhara T, Sato K. Virological characteristics of the SARS-CoV-2 BA.2.86 variant. Cell Host Microbe. 32(2):170-180.e12. https://doi.org/10.1016/j.chom.2024.01.001 (2024)

論文解説　オミクロンBA.2.86株のウイルス学的特性の解明

117. Halfmann PJ, Loeffler K, Duffy A, Kuroda M, Yang JE, Wright ER, Kawaoka Y, Kane RS. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine. Nat Commun. 15(1):1284-6. https://doi.org/10.1038/s41467-024-45495-6 (2024)

118. Tamura T, Irie T, Deguchi S, Yajima H, Tsuda M, Nasser H, Mizuma K, Plianchaisuk A, Suzuki S, Uriu K, Begum MM, Shimizu R, Jonathan M, Suzuki R, Kondo T, Ito H, Kamiyama A, Yoshimatsu K, Shofa M, Hashimoto R, Anraku Y, Kimura KT, Kita S, Sasaki J, Sasaki-Tabata K, Maenaka K, Nao N, Wang L, Oda Y, Sawa H, Kawabata R, Watanabe Y, Sakamoto A, Yasuhara N, Suzuki T, Nakajima Y, Ferdous Z, Shishido K, Mugita Y, Takahashi O, Ichihara K, Kaku Y, Misawa N, Guo Z, Hinay A, Jr., Kosugi Y, Fujita S, Tolentino JM, Chen L, Pan L, Suganami M, Chiba M, Yoshimura R, Yasuda K, Iida K, Ohsumi N, Strange AP, Shibatani Y, Nishiuchi T, Tanaka S, Putri O, Joas G, Kim Y, Yamasoba D, Yoshimura K, Sadamasu K, Nagashima M, Asakura H, Yoshida I, Nakagawa S, Takaori-Kondo A, Shirakawa K, Nagata K, Nomura R, Horisawa Y, Tashiro Y, Kawai Y, Ueno T, Motozono C, Toyoda M, Ikeda T, Saito A, Matsuno K, Ito J, Tanaka S, Sato K, Hashiguchi T, Takayama K, Fukuhara T, Genotype Phenotype Japan G. Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant. Nature Communications. 15(1):1176. https://doi.org/10.1038/s41467-024-45274-3 (2024)

論文解説　オミクロンXBB.1.5のウイルス学的特性の解明 ～新型コロナウイルスの生態の全容解明に貢献すると期待～

119. Izume T, Kawahara R, Uwamizu A, Chen L, Yaginuma S, Omi J, Kawana H, Hou F, Sano FK, Tanaka T, Kobayashi K, Okamoto HH, Kise Y, Ohwada T, Aoki J, Shihoya W, Nureki O. Structural basis for lysophosphatidylserine recognition by GPR34. Nat Commun. 15(1):902-z. https://doi.org/10.1038/s41467-024-45046-z (2024)

120. Kaku Y, Padilla-Blanco M, Kosugi Y, Uriu K, Hinay AAJ, Chen L, Plianchaisuk A, Kobiyama K, Ishii KJ, Genotype to Phenotype Japan (G2P-Japan) Consortium, Zahradnik J, Ito J, Sato K. Virological characteristics of the SARS-CoV-2 JN.1 variant. Lancet Infect Dis. 24(2):e82-7. Epub 2024 Jan 3. https://doi.org/10.1016/S1473-3099(23)00813-7 (2024)

論文解説　SARS-CoV-2オミクロンJN.1株のウイルス学的特性の解明

121. Belongia EA, Petrie JG, Feldstein LR, Guan L, Halfmann PJ, King JP, Neumann G, Pattinson D, Rolfes MA, McLean HQ, Kawaoka Y. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection. J Pediatric Infect Dis Soc. 13(1):100-104. https://doi.org/10.1093/jpids/piad109 (2024)

122. Takeda M. Cleavage-Activation of Respiratory Viruses - Half a Century of History from Sendai Virus to SARS-CoV-2. Jpn J Infect Dis. 77(1):1–6. https://doi.org/10.7883/yoken.JJID.2023.353 (2024)

123. Yamayoshi S, Nagai E, Mitamura K, Hagihara M, Kobayashi R, Takahashi S, Shibata A, Uwamino Y, Hasegawa N, Iqbal A, Kamimaki I, Iwatsuki-Horimoto K, Nagamura-Inoue T, Kawaoka Y. Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan. Epidemiol Infect. 152:e24. https://doi.org/10.1017/S0950268824000141 (2024)

124. Oshima HS, Sano FK, Akasaka H, Iwama A, Shihoya W, Nureki O. Optimizing cryo-EM structural analysis of G(i)-coupling receptors via engineered G(t) and Nb35 application. Biochem Biophys Res Commun. 693:149361. https://doi.org/10.1016/j.bbrc.2023.149361 (2024)

125. Maruki T, Nomoto H, Iwamoto N, Yamamoto K, Kurokawa M, Iwatsuki-Horimoto K, Yamayoshi S, Suzuki Y, Kawaoka Y, Ohmagari N. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma. J Infect Chemother. https://doi.org/10.1016/j.jiac.2024.01.008 (2024)

126. Hirohata K, Yamaguchi Y, Maruno T, Shibuya R, Torisu T, Onishi T, Chono H, Mineno J, Yuzhe Y, Higashiyama K, Masumi-Koizumi K, Uchida K, Yamamoto T, Uchida E, Okada T, Uchiyama S. Applications and Limitations of Equilibrium Density Gradient Analytical Ultracentrifugation for the Quantitative Characterization of Adeno-Associated Virus Vectors. Analytical chemistry (Washington). 96(2):642–651. https://doi.org/10.1021/acs.analchem.3c01955 (2024) 

127. Kosugi Y, Plianchaisuk A, Putri O, Uriu K, Kaku Y, Hinay AAJ, Chen L, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M, Ito J, Genotype to Phenotype Japan (G2P-Japan) Consortium, Sato K. Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution. Lancet Microbe. 5(4):e313–7. Epub 2024 Jan 11. https://doi.org/10.1016/S2666-5247(23)00373-7 (2024)

128. Whitworth IT, Knoener RA, Puray-Chavez M, Halfmann P, Romero S, Baddouh M, Scalf M, Kawaoka Y, Kutluay SB, Smith LM, Sherer NM. Defining Distinct RNA-Protein Interactomes of SARS-CoV-2 Genomic and Subgenomic RNAs. J Proteome Res. 23(1):149-160. https://doi.org/10.1021/acs.jproteome.3c00506 (2024)

129. Maharana J, Sano FK, Sarma P, Yadav MK, Duan L, Stepniewski TM, Chaturvedi M, Ranjan A, Singh V, Saha S, Mahajan G, Chami M, Shihoya W, Selent J, Chung KY, Banerjee R, Nureki O, Shukla AK. Molecular insights into atypical modes of β-arrestin interaction with seven transmembrane receptors. Science. 383(6678):101-108. https://doi.org/10.1126/science.adj3347 (2024)

130. Komatsu M, Inada T, Noda NN. The UFM1 system: Working principles, cellular functions, and pathophysiology. Mol Cell. 84(1):156–169. https://doi.org/10.1016/j.molcel.2023.11.034 (2024)

131. Ohira T, Suzuki T. Transfer RNA modifications and cellular thermotolerance. Molecular cell. 84(1):94–106. https://doi.org/10.1016/j.molcel.2023.11.041 (2024) 

132. Ishizaka A, Koga M, Mizutani T, Yamayoshi S, Iwatsuki-Horimoto K, Adachi E, Suzuki Y, Kawaoka Y, Yotsuyanagi H. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV. BMC Microbiol. 24(1):6-5. https://doi.org/10.1186/s12866-023-03157-5 (2024)

133. Uraki R, Imai M, Ito M, Yamayoshi S, Kiso M, Jounai N, Miyaji K, Iwatsuki-Horimoto K, Takeshita F, Kawaoka Y. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants. NPJ Vaccines. 9(1):4-0. https://doi.org/10.1038/s41541-023-00800-0 (2024)

134. Ekemen S, Bilir E, Soultan HEA, Zafar S, Demir F, Tabandeh B, Toprak S, Yapicier O, Coban C. The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors. Breast Cancer (Dove Med Press). 16:1–13. https://doi.org/10.2147/BCTT.S444077 (2024)

135. Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T, Inoue M, Sakai-Tagawa Y, Ito M, Yamayoshi S, Iwatsuki-Horimoto K, Suzuki Y, Kawaoka Y. Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies. Intern Med. https://doi.org/10.2169/internalmedicine.2900-23 (2024)

136. Hiraizumi M, Akashi T, Murasaki K, Kishida H, Kumanomidou T, Torimoto N, Nureki O, Miyaguchi I. Transport and inhibition mechanism of the human SGLT2-MAP17 glucose transporter. Nat Struct Mol Biol. 31(1):159-169. https://doi.org/10.1038/s41594-023-01134-0 (2024)

137. Miyake K, Shibata T, Fukui R, Murakami Y, Sato R, Hiranuma R. Endosomal Toll-Like Receptors as Therapeutic Targets for Autoimmune Diseases. Basic Immunology and its Clinical Application. 1444:97–108. https://doi.org/10.1007/978-981-99-9781-7_7 (2024)

138. Shinkura R. Development of Orally Ingestible IgA Antibody Drugs to Maintain Symbiosis Between Humans and Microorganisms. Advances in experimental medicine and biology. 1444:165–176. https://doi.org/10.1007/978-981-99-9781-7_11 (2024) 

139. Inoue Y, Sato S, Ri I, Mimura K, Kitao M, Kamisato A, Muto K. Ethics Review Committees of Public Health Institutes in Japan. Nihon Eiseigaku Zasshi. 79:10.1265/jjh.24002. https://doi.org/10.1265/jjh.24002 (2024)

2023

1. Watanabe N, Saito-Nakano Y, Kurisawa N, Otomo K, Suenaga K, Nakano K, Nozaki T. Fumagillin inhibits growth of the enteric protozoan parasite Entamoeba histolytica by covalently binding to and selectively inhibiting methionine aminopeptidase 2. Antimicrob Agents Chemother. 67(11):e0056023. https://doi.org/10.1128/aac.00560-23 (2023)

2. Kimura I, Yamasoba D, Nasser H, Ito H, Zahradnik J, Wu J, Fujita S, Uriu K, Sasaki J, Tamura T, Suzuki R, Deguchi S, Plianchaisuk A, Yoshimatsu K, Kazuma Y, Mitoma S, Schreiber G, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Takaori-Kondo A, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Shirakawa K, Takayama K, Irie T, Hashiguchi T, Nakagawa S, Fukuhara T, Saito A, Ikeda T, Sato K. Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics. J Virol. 97(10):e0101123-23. Epub 2023 Oct 5. https://doi.org/10.1128/jvi.01011-23 (2023)

3. 武藤 香織. 3）COVID-19 をめぐる倫理的諸課題. 日本内科学会雑誌. 112:101b. https://doi.org/10.2169/naika.112.101b (2023)

4. Uraki R, Kiso M, Iwatsuki-Horimoto K, Yamayoshi S, Ito M, Chiba S, Sakai-Tagawa Y, Imai M, Kashima Y, Koga M, Fuwa N, Okumura N, Hojo M, Iwamoto N, Kato H, Nakajima H, Ohmagari N, Yotsuyanagi H, Suzuki Y, Kawaoka Y. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo. Cell Rep. 42(12):113580. https://doi.org/10.1016/j.celrep.2023.113580 (2023)

論文解説　新型コロナウイルス・オミクロン株EG.5.1系統は、 ハムスターで初期のオミクロン系統よりも伝播しやすい

5. Masuda Y, Nasser H, Zahradnik J, Mitoma S, Shimizu R, Nagata K, Takaori-Kondo A, Schreiber G, Shirakawa K, Saito A, Ikeda T, Ito J, Sato K. Characterization of the evolutionary and virological aspects of mutations in the receptor binding motif of the SARS-CoV-2 spike protein. Frontiers in Virology. 3:1328229. https://doi.org/10.3389/fviro.2023.1328229 (2023)

6. Yamanouchi D, Kasuya G, Nakajo K, Kise Y, Nureki O. Dual allosteric modulation of voltage and calcium sensitivities of the Slo1-LRRC channel complex. Mol Cell. 83(24):4555-4569.e4. https://doi.org/10.1016/j.molcel.2023.11.005 (2023)

7. Yoshida K, Tsunekawa Y, Kurihara K, Watanabe K, Makino-Manabe Y, Wada M, Tanaka T, Ide T, Okada T. Engineering a highly durable adeno-associated virus receptor for analytical applications. Molecular therapy. Methods & clinical development. 31:101157. https://doi.org/10.1016/j.omtm.2023.101157 (2023) 

8. Safari C, Ghosh S, Andersson R, Johannesson J, Bath P, Uwangue O, Dahl P, Zoric D, Sandelin E, Vallejos A, Nango E, Tanaka R, Bosman R, Borjesson P, Dunevall E, Hammarin G, Ortolani G, Panman M, Tanaka T, Yamashita A, Arima T, Sugahara M, Suzuki M, Masuda T, Takeda H, Yamagiwa R, Oda K, Fukuda M, Tosha T, Naitow H, Owada S, Tono K, Nureki O, Iwata S, Neutze R, Branden G. Time-resolved serial crystallography to track the dynamics of carbon monoxide in the active site of cytochrome c oxidase. Sci Adv. 9(49):eadh4179. https://doi.org/10.1126/sciadv.adh4179 (2023)

9. Zhao X, Ma D, Ishiguro K, Saito H, Akichika S, Matsuzawa I, Mito M, Irie T, Ishibashi K, Wakabayashi K, Sakaguchi Y, Yokoyama T, Mishima Y, Shirouzu M, Iwasaki S, Suzuki T, Suzuki T. Glycosylated queuosines in tRNAs optimize translational rate and post-embryonic growth. Cell. 186(25) https://doi.org/10.1016/j.cell.2023.10.026 (2023)

10. Yamayoshi S, Ito M, Iwatsuki-Horimoto K, Yasuhara A, Okuda M, Hamabata T, Murakami J, Duong C, Yamamoto T, Kuroda Y, Maeda K, Kawaoka Y. Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan. One Health. 17:100588. https://doi.org/10.1016/j.onehlt.2023.100588 (2023)

11. Hiramoto T, Inaba H, Baatartsogt N, Kashiwakura Y, Hayakawa M, Kamoshita N, Nishimasu H, Nureki O, Kinai E, Ohmori T. Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A. Blood Adv. 7(22):7017-7027. https://doi.org/10.1182/bloodadvances.2023010838 (2023)

12. Kingstad-Bakke B, Cleven T, Bussan H, Yount BL,Jr, Uraki R, Iwatsuki-Horimoto K, Koga M, Yamamoto S, Yotsuyanagi H, Park H, Mishra JS, Kumar S, Baric RS, Halfmann PJ, Kawaoka Y, Suresh M. Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine. JCI Insight. 8(22):e172510. doi: 10.1172/jci.insight.172510. https://doi.org/10.1172/jci.insight.172510 (2023)

13. Iwatsuki-Horimoto K, Ito M, Okuda-Hamabata M, Takagi H, Imai M, Kawaoka Y. Cardiomyopathy Does Not Exacerbate the Severity of Pneumonia Caused by a SARS-CoV-2 Delta Variant in the J2N-k Hamster Model. Viruses. 15(12):2280. doi: 10.3390/v15122280. https://doi.org/10.3390/v15122280 (2023)

14. Kuroda M, Halfmann PJ, Thackray LB, Diamond MS, Feldmann H, Marzi A, Kawaoka Y. An Antiviral Role for TRIM14 in Ebola Virus Infection. J Infect Dis. 228:S514-S521. https://doi.org/10.1093/infdis/jiad325 (2023a)

15. Halfmann PJ, Borisevich V, Levine CB, Mire CE, Fenton KA, Geisbert TW, Kawaoka Y, Cross RW. The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets. J Infect Dis. 228:S587-S593. https://doi.org/10.1093/infdis/jiad240 (2023)

16. Kuroda M, Halfmann PJ, Kawaoka Y. Ebola Virus Infection Induces HCAR2 Expression Leading to Cell Death. J Infect Dis. 228:S508-S513. https://doi.org/10.1093/infdis/jiad344 (2023b)

17. Kobayashi D, Kai I, Faizah AN, Moi ML, Tajima S, Takasaki T, Sasaki T, Isawa H. Comparative analysis of the susceptibility of Aedes aegypti and Japanese Aedes albopictus to all dengue virus serotypes. Trop Med Health. 51(1):61-5. https://doi.org/10.1186/s41182-023-00553-5 (2023)

18. Maemura T, Guan L, Gu C, Eisfeld A, Biswas A, Halfmann P, Neumann G, Kawaoka Y. Characterization of highly pathogenic clade 2.3.4.4b H5N1 mink influenza viruses. EBioMedicine. 97:104827. https://doi.org/10.1016/j.ebiom.2023.104827 (2023)

論文解説　ミンク由来高病原性H5N1鳥インフルエンザウイルスの性状解析

19. Miyaoka R, Tsunekawa Y, Kurosawa Y, Sasaki T, Onodera A, Sakamoto K, Kakiuchi Y, Wada M, Nitahara‐Kasahara Y, Hayashita‐Kinoh H, Okada T. Development of a novel purification method for AAV vectors using tangential flow filtration. Biotechnology and bioengineering. 120(11):3311–3321. https://doi.org/10.1002/bit.28524 (2023)  

20. Ota M, Nakano M, Nagafuchi Y, Kobayashi S, Hatano H, Yoshida R, Akutsu Y, Itamiya T, Ban N, Tsuchida Y, Shoda H, Yamamoto K, Ishigaki K, Okamura T, Fujio K. Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases. Ann Rheum Dis. 82(11):1455-1463. https://doi.org/10.1136/ard-2023-224421 (2023)

21. Uriu K, Ito J, Kosugi Y, Tanaka YL, Mugita Y, Guo Z, Hinay AAJ, Putri O, Kim Y, Shimizu R, Begum MM, Jonathan M, Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Ikeda T, Sato K. Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant. Lancet Infect Dis. 23(11):e460-e461. https://doi.org/10.1016/S1473-3099(23)00575-3 (2023)

論文解説　SARS-CoV-2オミクロンBA.2.86株の 伝播力、感染性および免疫抵抗性

22. Dzau V, Swaminathan S, Baker C, Bright RA, Castillo J, Chuan TC, Draghia-Akli R, Eardley-Patel R, Gao GF, Ishii K, Tebeje YK, Lambe T, Machingaidze S, Rottingen J, Shaligram U, Simao M, Swarup R, Toussaint J, Wairagkar NS. The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation. Lancet. 402(10412):1507-1510. https://doi.org/10.1016/S0140-6736(23)01775-0 (2023)

23. Hino T, Omura SN, Nakagawa R, Togashi T, Takeda SN, Hiramoto T, Tasaka S, Hirano H, Tokuyama T, Uosaki H, Ishiguro S, Kagieva M, Yamano H, Ozaki Y, Motooka D, Mori H, Kirita Y, Kise Y, Itoh Y, Matoba S, Aburatani H, Yachie N, Karvelis T, Siksnys V, Ohmori T, Hoshino A, Nureki O. An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis. Cell. 186(22):4920-4935.e23. https://doi.org/10.1016/j.cell.2023.08.031 (2023)

24. Shoda H, Natsumoto B, Fujio K. Investigation of immune-related diseases using patient-derived induced pluripotent stem cells. Inflamm Regen. 43(1):51-4. https://doi.org/10.1186/s41232-023-00303-4 (2023)

25. Wang Y, Morishima T, Sezaki M, Sato R, Nakato G, Fukuda S, Kobiyama K, Ishii KJ, Li Y, Takizawa H. Akkermansia muciniphila induces slow extramedullary hematopoiesis via cooperative IL-1R/TLR signals. EMBO Rep. :e57485. https://doi.org/10.15252/embr.202357485 (2023)

26. Fujita S, Uriu K, Pan L, Nao N, Tabata K, Kishimoto M, Itakura Y, Sawa H, Kida I, Tamura T, Fukuhara T, Ito J, Matsuno K, Sato K, Consortium G. Impact of Imprinted Immunity Induced by mRNA Vaccination in an Experimental Animal Model. J Infect Dis. 228(8):1060–1065. https://doi.org/10.1093/infdis/jiad230 (2023)

27. Koda T, Natsumoto B, Shoda H, Fujio K. Nonepisodic Angioedema with Eosinophilia Following Receipt of the BNT162b2 mRNA COVID-19 Vaccine. Intern Med. 62(20):3063-3067. https://doi.org/10.2169/internalmedicine.1788-23 (2023)

28. Wilks SH, Mühlemann B, Shen X, Türeli S, LeGresley EB, Netzl A, Caniza MA, Chacaltana-Huarcaya J, Corman VM, Daniell X, Datto MB, Dawood FS, Denny TN, Drosten C, Fouchier RAM, Garcia PJ, Halfmann PJ, Jassem A, Jeworowski LM, Jones TC, Kawaoka Y, Krammer F, McDanal C, Pajon R, Simon V, Stockwell MS, Tang H, van Bakel H, Veguilla V, Webby R, Montefiori DC, Smith DJ. Mapping SARS-CoV-2 antigenic relationships and serological responses. Science. 382(6666):eadj0070. https://doi.org/10.1126/science.adj0070 (2023)

29. Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito M, Tsutsumi T, Otani A, Fukushi S, Watanabe S, Suzuki T, Kikuchi T, Yotsuyanagi H, Maeda K, Kawaoka Y. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate. iScience. 26(11):108147. https://doi.org/10.1016/j.isci.2023.108147 (2023)

論文解説　新型コロナウイルス・オミクロン株のXBB.1.9.1系統は XBB.1.5系統と類似の性状を持つ

30. Kikuchi C, Antonopoulos A, Wang S, Maemura T, Karamanska R, Lee C, Thompson AJ, Dell A, Kawaoka Y, Haslam SM, Paulson JC. Glyco-engineered MDCK cells display preferred receptors of H3N2 influenza absent in eggs used for vaccines. Nat Commun. 14(1):6178-0. https://doi.org/10.1038/s41467-023-41908-0 (2023)

31. Scarno G, Mazej J, Laffranchi M, Di Censo C, Mattiola I, Candelotti AM, Pietropaolo G, Stabile H, Fionda C, Peruzzi G, Brooks SR, Tsai WL, Mikami Y, Bernardini G, Gismondi A, Sozzani S, Di Santo JP, Vosshenrich CAJ, Diefenbach A, Gadina M, Santoni A, Sciume G. Divergent roles for STAT4 in shaping differentiation of cytotoxic ILC1 and NK cells during gut inflammation. Proc Natl Acad Sci U S A. 120(40):e2306761120. https://doi.org/10.1073/pnas.2306761120 (2023)

32. Katsikis PD, Ishii KJ, Schliehe C. Challenges in developing personalized neoantigen cancer vaccines. Nat Rev Immunol. https://doi.org/10.1038/s41577-023-00937-y (2023)

33. Kaku Y, Kosugi Y, Uriu K, Ito J, Hinay AAJ, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M, Genotype to Phenotype Japan (G2P-Japan) Consortium, Sato K. Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5. Lancet Infect Dis. 23(10):e395-e396. https://doi.org/10.1016/S1473-3099(23)00553-4 (2023)

論文解説　SARS-CoV-2 XBBブレイクスルー感染者血清の、 EG.5を含むオミクロン変異株への抗ウイルス作用の解析

34. Kashima Y, Mizutani T, Okimoto Y, Maeda M, Musashino K, Nishide R, Matsukura A, Nagase J, Suzuki Y. Evolution of the viral genomes of SARS-CoV-2 in association with the changes in local condition: a genomic epidemiological study of a suburban city of Japan. DNA Res. 30(5):dsad020. doi: 10.1093/dnares/dsad020. https://doi.org/10.1093/dnares/dsad020 (2023)

35. Hou YJ, Chiba S, Leist SR, Meganck RM, Martinez DR, Schafer A, Catanzaro NJ, Sontake V, West A, Edwards CE, Yount B, Lee RE, Gallant SC, Zost SJ, Powers J, Adams L, Kong EF, Mattocks M, Tata A, Randell SH, Tata PR, Halfmann P, Crowe JE,Jr, Kawaoka Y, Baric RS. Host range, transmissibility and antigenicity of a pangolin coronavirus. Nat Microbiol. 8(10):1820-1833. https://doi.org/10.1038/s41564-023-01476-x (2023)

36. Hirano M, Yamada Y. Reprogramming of pancreatic islet cells for regeneration and rejuvenation. Curr Opin Genet Dev. 82:102099. https://doi.org/10.1016/j.gde.2023.102099 (2023)

37. Zhang Z, Shibata T, Fujimura A, Kitaura J, Miyake K, Ohto U, Shimizu T. Structural basis for thioredoxin-mediated suppression of NLRP1 inflammasome. Nature. 622(7981):188-194. https://doi.org/10.1038/s41586-023-06532-4 (2023)

38. Shihoya W, Sano FK, Nureki O. Structural insights into endothelin receptor signalling. J Biochem. 174(4):317-325. https://doi.org/10.1093/jb/mvad055 (2023)

39. Zhuo S, Noda N, Hioki K, Jin S, Hayashi T, Hiraga K, Momose H, Li W, Zhao L, Mizukami T, Ishii KJ, Li Y, Uesugi M. Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile. J Med Chem. 66(18):13266-13279. https://doi.org/10.1021/acs.jmedchem.3c01252 (2023)

40. Dott T, Culina S, Chemali R, Mansour CA, Dubois F, Jagla B, Doisne JM, Rogge L, Huetz F, Jonsson F, Commere P, Di Santo J, Terrier B, Quintana-Murci L, Duffy D, Hasan M, Milieu IC. Standardized high-dimensional spectral cytometry protocol and panels for whole blood immune phenotyping in clinical and translational studies. Cytometry A. https://doi.org/10.1002/cyto.a.24801 (2023)

41. Yao L, Chemaitelly H, Goldman E, Gudina EK, Khalil A, Ahmed R, James AB, Roca A, Fallah MP, Macnab A, Cho WC, Eikelboom J, Qamar FN, Kremsner P, Oliu-Barton M, Sisa I, Tadesse BT, Marks F, Wang L, Kim JH, Meng X, Wang Y, Fly AD, Wang C, Day SW, Howard SC, Graff JC, Maida M, Ray K, Franco-Paredes C, Mashe T, Ngongo N, Kaseya J, Ndembi N, Hu Y, Bottazzi ME, Hotez PJ, Ishii KJ, Wang G, Sun D, Aleya L, Gu W. Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community's view. EClinicalMedicine. 64:102222. https://doi.org/10.1016/j.eclinm.2023.102222 (2023)

42. Chiba S, Halfmann PJ, Iida S, Hirata Y, Sato Y, Kuroda M, Armbrust T, Spyra S, Suzuki T, Kawaoka Y. Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2. Vaccine. 41(41):6025-6035. https://doi.org/10.1016/j.vaccine.2023.08.054 (2023)

43. Fujita S, Kosugi Y, Kimura I, Tokunaga K, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Sato K. Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2. J Virol. :e0099023. https://doi.org/10.1128/jvi.00990-23 (2023)

44. Ueno H, Sano M, Hara M, Noji H. Digital Cascade Assays for ADP- or ATP-Producing Enzymes Using a Femtoliter Reactor Array Device. ACS sensors. 8(9):3400–3407. https://doi.org/10.1021/acssensors.3c00587 (2023) 

45. Komagamine M, Komatsu N, Ling R, Okamoto K, Tianshu S, Matsuda K, Takeuchi T, Kaneko Y, Takayanagi H. Effect of JAK inhibitors on the three forms of bone damage in autoimmune arthritis: joint erosion, periarticular osteopenia, and systemic bone loss. Inflamm Regen. 43(1):44-3. https://doi.org/10.1186/s41232-023-00293-3 (2023)

46. Inoue M, Nagafuchi Y, Ota M, Tsuchiya H, Tateishi S, Kanda H, Fujio K. Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis. Sci Rep. 13(1):15250-6. https://doi.org/10.1038/s41598-023-42324-6 (2023)

47. Jeelani G, Balogun EO, Husain A, Nozaki T. Glycerol biosynthetic pathway plays an essential role in proliferation and antioxidative defense in the human enteric protozoan parasite Entamoeba histolytica. Sci Rep. 13(1):14596. https://doi.org/10.1038/s41598-023-40670-z (2023) 

48. Shibata T, Sato R, Taoka M, Saitoh S, Komine M, Yamaguchi K, Goyama S, Motoi Y, Kitaura J, Izawa K, Yamauchi Y, Tsukamoto Y, Ichinohe T, Fujita E, Hiranuma R, Fukui R, Furukawa Y, Kitamura T, Takai T, Tojo A, Ohtsuki M, Ohto U, Shimizu T, Ozawa M, Yoshida N, Isobe T, Latz E, Mukai K, Taguchi T, Hemmi H, Akira S, Miyake K. TLR7/8 stress response drives histiocytosis in SLC29A3 disorders. J Exp Med. 220(9):e20230054. doi: 10.1084/jem.20230054. Epub 2023 Jul 18. https://doi.org/10.1084/jem.20230054 (2023)

49. Kimura A, Takagi T, Thamamongood T, Sakamoto S, Ito T, Seki I, Okamoto M, Aono H, Serada S, Naka T, Imataka H, Miyake K, Ueda T, Miyanokoshi M, Wakasugi K, Iwamoto N, Ohmagari N, Iguchi T, Nitta T, Takayanagi H, Yamashita H, Kaneko H, Tsuchiya H, Fujio K, Handa H, Suzuki H. Extracellular aaRSs drive autoimmune and inflammatory responses in rheumatoid arthritis via the release of cytokines and PAD4. Ann Rheum Dis. 82(9):1153-1161. https://doi.org/10.1136/ard-2023-224055 (2023)

50. Amai M, Nojima M, Yuki Y, Kiyono H, Nagamura F. A review of criteria strictness in “Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials”. Vaccine. 41(38):5622–5629. https://doi.org/10.1016/j.vaccine.2023.07.072 (2023) 

51. Fukui A, Maruzuru Y, Ohno S, Nobe M, Iwata S, Takeshima K, Koyanagi N, Kato A, Kitazume S, Yamaguchi Y, Kawaguchi Y. Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence. mBio. 14(4):e0099223-23. Epub 2023 Jun 27. https://doi.org/10.1128/mbio.00992-23 (2023)

52. Chiba S, Kong H, Neumann G, Kawaoka Y. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes. mBio. 14(4):e0062223-23. Epub 2023 Jul 19. https://doi.org/10.1128/mbio.00622-23 (2023)

論文解説　インフルエンザウイルスHAの変異し難い部位をねらう　ワクチン抗原のデザイン　 ―ユニバーサルワクチンの新規ストラテジー―

53. Abeygoonawardena H, Wijesinghe N, Navaratne V, Balasuriya A, Nguyen TTN, Moi ML, De Silva AD. Serological Evidence of Zika virus Circulation with Dengue and Chikungunya Infections in Sri Lanka from 2017. J Glob Infect Dis. 15(3):113-120. https://doi.org/10.4103/jgid.jgid_195_22 (2023)

54. Mise-Omata S, Ando M, Srirat T, Nakagawara K, Hayakawa T, Iizuka-Koga M, Nishimasu H, Nureki O, Ito M, Yoshimura A. SOCS3 deletion in effector T cells confers an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine. Cell Rep. 42(8):112940. https://doi.org/10.1016/j.celrep.2023.112940 (2023)

55. Thaller AL, Jonsson F, Fiquet O, Marie S, Doisne J, Girelli-Zubani G, Eri T, Fernandes P, Tatirovsky E, Langa-Vives F, Bruhns P, Strick-Marchand H, Di Santo JP. A human immune system (HIS) mouse model that dissociates roles for mouse and human FcR(+) cells during antibody-mediated immune responses. Eur J Immunol. :e2350454. https://doi.org/10.1002/eji.202350454 (2023)

56. Ishimura R, Ito S, Mao G, Komatsu-Hirota S, Inada T, Noda NN, Komatsu M. Mechanistic insights into the roles of the UFM1 E3 ligase complex in ufmylation and ribosome-associated protein quality control. Sci Adv. 9(33):eadh3635. https://doi.org/10.1126/sciadv.adh3635 (2023)

57. Guan L, Ping J, Lopes TJS, Fan S, Presler R, Neumann G, Kawaoka Y. Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs. Vaccines (Basel). 11(8):1364. doi: 10.3390/vaccines11081364. https://doi.org/10.3390/vaccines11081364 (2023)

58. Yan M, Tsukasaki M, Muro R, Ando Y, Nakamura K, Komatsu N, Nitta T, Okamura T, Okamoto K, Takayanagi H. Identification of an intronic enhancer regulating RANKL expression in osteocytic cells. Bone Res. 11(1):43-6. https://doi.org/10.1038/s41413-023-00277-6 (2023)

59. Tomoda E, Nagao A, Shirai Y, Asano K, Suzuki T, Battersby BJ, Suzuki T. Restoration of mitochondrial function through activation of hypomodified tRNAs with pathogenic mutations associated with mitochondrial diseases. Nucleic Acids Res. 51(14):7563-7579. https://doi.org/10.1093/nar/gkad139 (2023)

60. Ueda S, Yagi M, Tomoda E, Matsumoto S, Ueyanagi Y, Do Y, Setoyama D, Matsushima Y, Nagao A, Suzuki T, Ide T, Mori Y, Oyama N, Kang D, Uchiumi T. Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation. Nucleic acids research. 51(14):7480–7495. https://doi.org/10.1093/nar/gkad591 (2023) 

61. Takashita E, Fujisaki S, Morita H, Nagata S, Miura H, Nagashima M, Watanabe S, Takeda M, Kawaoka Y, Hasegawa H. Assessment of the frequency of SARS-CoV-2 Omicron variant escape from RNA-dependent RNA polymerase inhibitors and 3C-like protease inhibitors. Antiviral Res. 216:105671. https://doi.org/10.1016/j.antiviral.2023.105671 (2023)

62. Omura SN, Nakagawa R, Südfeld C, Villegas Warren R, Wu WY, Hirano H, Laffeber C, Kusakizako T, Kise Y, Lebbink JHG, Itoh Y, van der Oost J, Nureki O. Mechanistic and evolutionary insights into a type V-M CRISPR-Cas effector enzyme. Nat Struct Mol Biol. 30(8):1172-1182. https://doi.org/10.1038/s41594-023-01042-3 (2023)

63. Ohta S, Yamada Y. Exploring the potential of in vivo reprogramming for studying embryonic development, tissue regeneration, and organismal aging. Curr Opin Genet Dev. 81:102067. https://doi.org/10.1016/j.gde.2023.102067 (2023)

64. Tamura T, Yamasoba D, Oda Y, Ito J, Kamasaki T, Nao N, Hashimoto R, Fujioka Y, Suzuki R, Wang L, Ito H, Kashima Y, Kimura I, Kishimoto M, Tsuda M, Sawa H, Yoshimatsu K, Yamamoto Y, Nagamoto T, Kanamune J, Suzuki Y, Ohba Y, Tabata K, Yokota I, Matsuno K, Takayama K, Tanaka S, Sato K, Fukuhara T, Genotype Phenotype Japan G2P-Japan. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5. Communications Biology. 6(1):772. https://doi.org/10.1038/s42003-023-05081-w (2023)

65. Guan L, Babujee L, Browning VL, Presler R, Pattinson D, Nguyen HLK, Hoang VMP, Le MQ, van Bakel H, Neumann G, Kawaoka Y. Continued Circulation of Highly Pathogenic H5 Influenza Viruses in Vietnamese Live Bird Markets in 2018-2021. Viruses. 15(7):1596. doi: 10.3390/v15071596. https://doi.org/10.3390/v15071596 (2023)

66. Yamada S, Nagafuchi Y, Fujio K. Pathophysiology and stratification of treatment-resistant rheumatoid arthritis. Immunol Med. :1-12. https://doi.org/10.1080/25785826.2023.2235734 (2023)

67. Kiso M, Yamayoshi S, Iida S, Furusawa Y, Hirata Y, Uraki R, Imai M, Suzuki T, Kawaoka Y. In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir. Nat Commun. 14(1):4231-1. https://doi.org/10.1038/s41467-023-40018-1 (2023)

論文解説　ゾコーバ耐性新型コロナウイルスの性状解析

68. Li J, Chen Z, Kim G, Luo J, Hori S, Wu C. Cathepsin W restrains peripheral regulatory T cells for mucosal immune quiescence. Sci Adv. 9(28):eadf3924. https://doi.org/10.1126/sciadv.adf3924 (2023)

69. Ishizaka A, Koga M, Mizutani T, Uraki R, Yamayoshi S, Iwatsuki-Horimoto K, Yamamoto S, Imai M, Tsutsumi T, Suzuki Y, Kawaoka Y, Yotsuyanagi H. Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination. Virol J. 20(1):146-z. https://doi.org/10.1186/s12985-023-02113-z (2023)

70. Kiso M, Yamayoshi S, Kawaoka Y. Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors. J Antimicrob Chemother. 78(7):1649-1657. https://doi.org/10.1093/jac/dkad145 (2023)

71. Kiso M, Furusawa Y, Uraki R, Imai M, Yamayoshi S, Kawaoka Y. In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir. Nat Commun. 14(1):3952-x. https://doi.org/10.1038/s41467-023-39704-x (2023)

論文解説　ニルマトレルビル耐性新型コロナウイルスの性状解析

72. Muramoto Y, Takahashi S, Halfmann PJ, Gotoh S, Noda T, Kawaoka Y. Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures. Lancet Microbe. 4(7):e486-3. Epub 2023 Apr 24. https://doi.org/10.1016/S2666-5247(23)00100-3 (2023)

論文解説　新型コロナウイルス・オミクロン株のBA.5系統およびBQ.1.1系統が、高温で増殖しづらいことを解明

73. Das K, Nozaki T. Non-Vesicular Lipid Transport Machinery in Leishmania donovani: Functional Implications in Host-Parasite Interaction. International Journal of Molecular Sciences. 24(13):10637. https://doi.org/10.3390/ijms241310637 (2023)

74. Nagai M, Moriyama M, Ishii C, Mori H, Watanabe H, Nakahara T, Yamada T, Ishikawa D, Ishikawa T, Hirayama A, Kimura I, Nagahara A, Naito T, Fukuda S, Ichinohe T. High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection. Nat Commun. 14(1):3863. https://doi.org/10.1038/s41467-023-39569-0 (2023) 

論文解説　発熱がウイルス性肺炎の重症化を抑制するメカニズムを解明 ――重症化の抑制には38℃以上の体温で活性化した腸内細菌叢が必要だった――

75. Yamamoto S, Yamayoshi S, Ito M, Sakai-Tagawa Y, Nakachi I, Baba R, Kamimoto S, Ogura T, Hagiwara S, Kato H, Nakajima H, Uwamino Y, Yagi K, Sugaya N, Nagai H, Saito M, Adachi E, Koga M, Tsutsumi T, Duong C, Okuda M, Murakami J, Furusawa Y, Ujie M, Iwatsuki-Horimoto K, Yotsuyanagi H, Kawaoka Y. Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination. iScience. 26(7):107208. https://doi.org/10.1016/j.isci.2023.107208 (2023)

76. Halfmann PJ, Uraki R, Kuroda M, Iwatsuki-Horimoto K, Yamayoshi S, Ito M, Kawaoka Y. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters. eBioMedicine. 93:104677. https://doi.org/10.1016/j.ebiom.2023.104677 (2023) 

論文解説　新型コロナウイルス・オミクロン株XBB.1.5系統は、 ハムスターで初期のオミクロン系統よりも伝播しやすい

77. Takeshita M, Fukuyama H, Kamada K, Matsumoto T, Makino-Okamura C, Lin Q, Sakuma M, Kawahara E, Yamazaki I, Uchikubo-Kamo T, Tomabechi Y, Hanada K, Hisano T, Moriyama S, Takahashi Y, Ito M, Imai M, Maemura T, Furusawa Y, Yamayoshi S, Kawaoka Y, Shirouzu M, Ishii M, Saya H, Kondo Y, Kaneko Y, Suzuki K, Fukunaga K, Takeuchi T, Keio DP. Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents. iScience. 26(6):106955. https://doi.org/10.1016/j.isci.2023.106955 (2023)

78. Moser MJ, Hill-Batorski L, Bowen RA, Matejka SM, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants. Vaccines (Basel). 11(6):1063. doi: 10.3390/vaccines11061063. https://doi.org/10.3390/vaccines11061063 (2023)

79. Nakajima-Takagi Y, Oshima M, Takano J, Koide S, Itokawa N, Uemura S, Yamashita M, Andoh S, Aoyama K, Isshiki Y, Shinoda D, Saraya A, Arai F, Yamaguchi K, Furukawa Y, Koseki H, Ikawa T, Iwama A. Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis. Elife. 12:10.7554/eLife.83004. https://doi.org/10.7554/eLife.83004 (2023)

80. Ichikawa A, Katayama M, Lai H, Wataru S, Takenaka-Uema A, Horimoto T, Murakami S. Isolation and genetic characterization of a mammalian orthoreovirus from Vespertilio sinensis in Japan. Arch Virol. 168(6):165. https://doi.org/10.1007/s00705-023-05782-x (2023) 

81. Kobayashi K, Kawakami K, Kusakizako T, Tomita A, Nishimura M, Sawada K, Okamoto HH, Hiratsuka S, Nakamura G, Kuwabara R, Noda H, Muramatsu H, Shimizu M, Taguchi T, Inoue A, Murata T, Nureki O. Class B1 GPCR activation by an intracellular agonist. Nature. 618(7967):1085-1093. https://doi.org/10.1038/s41586-023-06169-3 (2023)

82. Yamada S, Nagafuchi Y, Wang M, Ota M, Hatano H, Takeshima Y, Okubo M, Kobayashi S, Sugimori Y, Masahiro N, Yoshida R, Hanata N, Suwa Y, Tsuchida Y, Iwasaki Y, Sumitomo S, Kubo K, Shimane K, Setoguchi K, Azuma T, Kanda H, Shoda H, Zhang X, Yamamoto K, Ishigaki K, Okamura T, Fujio K. Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance. Ann Rheum Dis. 82(6):809-819. https://doi.org/10.1136/ard-2022-223645 (2023)

83. Tamura D, Kawaoka Y. Omicron proliferation in the nasal cavity may explain its high infectivity. J Infect. 86(6):584-587. https://doi.org/10.1016/j.jinf.2023.03.006 (2023)

84. Yamasoba D, Uriu K, Plianchaisuk A, Kosugi Y, Pan L, Zahradnik J, Genotype to Phenotype Japan (G2P-Japan) Consortium, Ito J, Sato K.  Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant. Lancet Infect Dis. 23(6):655-656. https://doi.org/10.1016/S1473-3099(23)00278-5 (2023)

論文解説　SARS-CoV-2オミクロンXBB.1.16株の ウイルス学的特性の解明

85. Saito Y, Takahashi T, Hiramatsu K, Serada S, Fujimoto M, Ohkawara T, Sugase T, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Nakajima K, Yamasaki M, Ishii KJ, Eguchi H, Doki Y, Naka T. Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody. Anticancer Res. 43(6):2425-2432. https://doi.org/10.21873/anticanres.16410 (2023)

86. Fujikawa D, Nakamura T, Yoshioka D, Li Z, Moriizumi H, Taguchi M, Tokai-Nishizumi N, Kozuka-Hata H, Oyama M, Takekawa M. Stress granule formation inhibits stress-induced apoptosis by selectively sequestering executioner caspases. Curr Biol. 33(10):1967-1981.e8. https://doi.org/10.1016/j.cub.2023.04.012 (2023)

論文解説　液-液相分離体「ストレス顆粒」形成による ストレス防御および癌進展機構の解明 ――ストレス環境下で細胞がアポトーシスを回避する新たな仕組みを発見――

87. Nakamura Y, Moi ML, Shiina T, Shin-I T, Suzuki R. Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases. Viruses-Basel. 15(5):1186. https://doi.org/10.3390/v15051186 (2023)

88. Nagao A, Nakanishi Y, Yamaguchi Y, Mishina Y, Karoji M, Toya T, Fujita T, Iwasaki S, Miyauchi K, Sakaguchi Y, Suzuki T. Quality control of protein synthesis in the early elongation stage. Nat Commun. 14(1):2704-5. https://doi.org/10.1038/s41467-023-38077-5 (2023)

89. Shibata K, Oda K, Nishizawa T, Hazama Y, Ono R, Takaramoto S, Bagherzadeh R, Yawo H, Nureki O, Inoue K, Akiyama H. Twisting and Protonation of Retinal Chromophore Regulate Channel Gating of Channelrhodopsin C1C2. J Am Chem Soc. 145(19):10779-10789. https://doi.org/10.1021/jacs.3c01879 (2023)

90. Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K, Genotype to Phenotype Japan (G2P-Japan) Consortium, Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun. 14(1):2800-3. https://doi.org/10.1038/s41467-023-38435-3 (2023)

論文解説　オミクロンXBB株の進化経路とウイルス学的特性の解明 ―遺伝子組換えによる更なる免疫逃避能力の獲得―

91. Ikeuchi K, Ivic N, Buschauer R, Cheng J, Froehlich T, Matsuo Y, Berninghausen O, Inada T, Becker T, Beckmann R. Molecular basis for recognition and deubiquitination of 40S ribosomes by Otu2. Nat Commun. 14(1):2730. https://doi.org/10.1038/s41467-023-38161-w (2023)

92. Ito J, Suzuki R, Uriu K, Itakura Y, Zahradnik J, Kimura KT, Deguchi S, Wang L, Lytras S, Tamura T, Kida I, Nasser H, Shofa M, Begum MM, Tsuda M, Oda Y, Suzuki T, Sasaki J, Sasaki-Tabata K, Fujita S, Yoshimatsu K, Ito H, Nao N, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Kuramochi J, Schreiber G, Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Matsuno K, Takayama K, Hashiguchi T, Tanaka S, Fukuhara T, Ikeda T, Sato K. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant. Nat Commun. 14(1):2671-z. https://doi.org/10.1038/s41467-023-38188-z (2023)

論文解説　SARS-CoV-2オミクロン株の進化パターンの一端を解明 ―スパイクタンパク質の収斂進化が適応度の高い変異株の出現に繋がる―

93. Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito M, Tsutsumi T, Otani A, Kashima Y, Kikuchi T, Theiler J, Yotsuyanagi H, Suzuki Y, Korber B, Kawaoka Y. Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate. Lancet Reg Health West Pac. 34:100777. https://doi.org/10.1016/j.lanwpc.2023.100777 (2023) 

論文解説　BA.4/5株対応2価mRNAワクチン接種で、 新型コロナウイルス・オミクロン株XBF系統に対する 中和活性は増強される

94. Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Furusawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito M, Tsutsumi T, Otani A, Kashima Y, Kikuchi T, Yotsuyanagi H, Suzuki Y, Kawaoka Y. Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1. Lancet Infect Dis. 23(5):525-526. https://doi.org/10.1016/S1473-3099(23)00132-9 (2023)

論文解説　新型コロナウイルス・オミクロン株のCH.1.1系統に対する 治療薬と2価ワクチンの効果を検証

95. Furusawa Y, Kiso M, Iida S, Uraki R, Hirata Y, Imai M, Suzuki T, Yamayoshi S, Kawaoka Y. In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters. EBioMedicine. 91:104561. https://doi.org/10.1016/j.ebiom.2023.104561 (2023)

論文解説　新型コロナウイルス・デルタ変異株の Spike-P681RおよびD950N変異の機能解析

96. Amada K, Hijiya N, Ikarimoto S, Yanagihara K, Hanada T, Hidano S, Kurogi S, Tsukamoto Y, Nakada C, Kinoshita K, Hirashita Y, Uchida T, Shin T, Yada K, Hirashita T, Kobayashi T, Murakami K, Inomata M, Shirao K, Aoki M, Takekawa M, Moriyama M. Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor. Cancer Sci. 114(5):2189-2202. https://doi.org/10.1111/cas.15735 (2023)

97. Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Wilson N, Bobholz M, Vuyk WC, Wei W, Ries H, O'Connor DH, Friedrich TC, Sordillo EM, van Bakel H, Simon V, Kawaoka Y. Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2. J Med Virol. 95(5):e28788. https://doi.org/10.1002/jmv.28788 (2023)

98. Chowdhury SI, Inui M, Yamazaki T, Tomono S, Takagi H, Biswas M, Saitoh S, Miyake K, Akashi-Takamura S. The anti-TLR4 monoclonal antibody Sa15-21 enhances inflammatory cytokine production in LPS-stimulated macrophages. FEBS Lett. 597(9):1246-1260. https://doi.org/10.1002/1873-3468.14619 (2023)

99. Otsuka Saito K, Fujita F, Toriyama M, Utami RA, Guo Z, Murakami M, Kato H, Suzuki Y, Okada F, Tominaga M, Ishii KJ. Roles of TRPM4 in immune responses in keratinocytes and identification of a novel TRPM4-activating agent. Biochem Biophys Res Commun. 654:1-9. https://doi.org/10.1016/j.bbrc.2023.02.062 (2023)

100. Guan L, Zhong G, Fan S, Plisch EM, Presler R, Gu C, Babujee L, Pattinson D, Le Khanh Nguyen H, Hoang VMP, Le MQ, van Bakel H, Neumann G, Kawaoka Y. Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird Markets. Viruses-Basel. 15(5):1093. https://doi.org/10.3390/v15051093 (2023)

101. Ekemen S, Comunoglu C, Kayhan CK, Bilir E, Cavusoglu I, Etiler N, Bilgi S, Ince U, Coban C, Erden HF. Endometrial Staining of CD56 (Uterine Natural Killer), BCL-6, and CD138 (Plasma Cells) Improve Diagnosis and Clinical Pregnancy Outcomes in Unexplained Infertility and Recurrent IVF Failures: Standardization of Diagnosis with Digital Pathology. Diagnostics. 13(9):1557. https://doi.org/10.3390/diagnostics13091557 (2023)

102. Sano F, Akasaka H, Shihoya W, Nureki O. Cryo-EM structure of the endothelin-1-ET(B)-G(i) complex. Elife. 12:10.7554/eLife.85821. https://doi.org/10.7554/eLife.85821 (2023)

103. Suzuki T, Yi C, Song J. Wolf Prize in Chemistry 2023: A Celebration for Chemical Biology. ACS chemical biology. 18(4):671–673. https://doi.org/10.1021/acschembio.3c00145 (2023) 

104. Hiramoto T, Kashiwakura Y, Hayakawa M, Baatartsogt N, Kamoshita N, Abe T, Inaba H, Nishimasu H, Uosaki H, Hanazono Y, Nureki O, Ohmori T. PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells. Commun Med (Lond). 3(1):56-w. https://doi.org/10.1038/s43856-023-00286-w (2023)

105. Changrob S, Halfmann PJ, Liu H, Torres JL, McGrath JJC, Ozorowski G, Li L, Wilbanks GD, Kuroda M, Maemura T, Huang M, Zheng N, Turner HL, Erickson SA, Fu Y, Yasuhara A, Singh G, Monahan B, Mauldin J, Srivastava K, Simon V, Krammer F, Sather DN, Ward AB, Wilson IA, Kawaoka Y, Wilson PC. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants. J Clin Invest. 133(8):e166844. doi: 10.1172/JCI166844. https://doi.org/10.1172/JCI166844 (2023)

106. Hill-Batorski L, Hatta Y, Moser MJ, Sarawar S, Neumann G, Kawaoka Y, Bilsel P. Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge. Vaccines (Basel). 11(4):798. doi: 10.3390/vaccines11040798. https://doi.org/10.3390/vaccines11040798 (2023)

107. Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Furusawa Y, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito M, Tsutsumi T, Otani A, Kikuchi T, Yotsuyanagi H, Halfmann PJ, Pekosz A, Kawaoka Y. Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate. Lancet Infect Dis. 23(4):402-403. https://doi.org/10.1016/S1473-3099(23)00070-1 (2023)

論文解説　新型コロナウイルス・オミクロン株のXBB.1.5系統に対する 治療薬とワクチンの効果を検証

108. Nakagawa R, Hirano H, Omura SN, Nety S, Kannan S, Altae-Tran H, Yao X, Sakaguchi Y, Ohira T, Wu WY, Nakayama H, Shuto Y, Tanaka T, Sano FK, Kusakizako T, Kise Y, Itoh Y, Dohmae N, van der Oost J, Suzuki T, Zhang F, Nureki O. Cryo-EM structure of the transposon-associated TnpB enzyme. Nature. 616(7956):390-397. https://doi.org/10.1038/s41586-023-05933-9 (2023)

News Release　Study reveals the 3D structure of a protein involved in genome editing

109. Moriizumi H, Kubota Y, Tsuchiya T, Naka R, Takekawa M. Caspase 3-specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress-induced apoptosis. FEBS Open Bio. 13(4):684-700. https://doi.org/10.1002/2211-5463.13574 (2023)

110. Saitoh H, Sakai-Tagawa Y, Nagasawa S, Torimitsu S, Kubota K, Hirata Y, Iwatsuki-Horimoto K, Motomura A, Ishii N, Okaba K, Horioka K, Abe H, Ikemura M, Rokutan H, Hinata M, Iwasaki A, Yasunaga Y, Nakajima M, Yamaguchi R, Tsuneya S, Kira K, Kobayashi S, Inokuchi G, Chiba F, Hoshioka Y, Mori A, Yamamoto I, Nakagawa K, Katano H, Iida S, Suzuki T, Akitomi S, Hasegawa I, Ushiku T, Yajima D, Iwase H, Makino Y, Kawaoka Y. High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19. Int J Infect Dis. 129:103-109. https://doi.org/10.1016/j.ijid.2023.01.046 (2023)

111. Sun X, Hosomi K, Shimoyama A, Yoshii K, Lan H, Wang Y, Yamaura H, Nagatake T, Ishii KJ, Akira S, Kiyono H, Fukase K, Kunisawa J. TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells. Int Immunopharmacol. 117:109852. https://doi.org/10.1016/j.intimp.2023.109852 (2023)

112. Wada M, Uchida N, Posadas-Herrera G, Hayashita-Kinoh H, Tsunekawa Y, Hirai Y, Okada T. Large-scale purification of functional AAV particles packaging the full genome using short-term ultracentrifugation with a zonal rotor. Gene Ther. 30(7-8):641–648. https://doi.org/10.1038/s41434-023-00398-x (2023)

113. Ito D, Ito H, Ando T, Sakai Y, Ideta T, Ishii KJ, Ishikawa T, Shimizu M. Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice. Hepatol Commun. 7(4):e0104. doi: 10.1097/HC9.0000000000000104. eCollection 2023 Apr 1. https://doi.org/10.1097/HC9.0000000000000104 (2023)

114. Uraki R, Iida S, Halfmann PJ, Yamayoshi S, Hirata Y, Iwatsuki-Horimoto K, Kiso M, Ito M, Furusawa Y, Ueki H, Sakai-Tagawa Y, Kuroda M, Maemura T, Kim T, Mine S, Iwamoto N, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Wang Z, Ohmagari N, Theiler J, Fischer W, Korber B, Imai M, Suzuki T, Kawaoka Y. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates. Nat Commun. 14(1):1620-x. https://doi.org/10.1038/s41467-023-37059-x (2023)

論文解説　新型コロナウイルス・オミクロン変異株のBA.2.75系統の性状解析

115. Furusawa Y, Yamayoshi S, Kawaoka Y. The accuracy of reverse genetics systems for SARS-CoV-2: Circular polymerase extension reaction versus bacterial artificial chromosome. Influenza Other Respir Viruses. 17(3):e13109. https://doi.org/10.1111/irv.13109 (2023)

116. Sukegawa S, Nureki O, Toki S, Saika H. Genome editing in rice mediated by miniature size Cas nuclease SpCas12f. Front Genome Ed. 5:1138843. https://doi.org/10.3389/fgeed.2023.1138843 (2023)

117. Tatsuma T, Nakakido M, Ichinohe T, Kuroiwa Y, Tomioka K, Liu C, Miyamae N, Onuki T, Tsumoto K, Hashimoto K, Wakihara T. Inactivation and spike protein denaturation of novel coronavirus variants by CuxO/TiO2 nano-photocatalysts. Sci Rep. 13(1) https://doi.org/10.1038/s41598-023-30690-0 (2023)

118. Ishida H, Murakami S, Kamiki H, Matsugo H, Katayama M, Sekine W, Ohira K, Takenaka-Uema A, Horimoto T. Generation of a recombinant temperature-sensitive influenza D virus. Sci Rep. 13(1):3806. https://doi.org/10.1038/s41598-023-30942-z (2023) 

119. Petrie JG, King JP, McClure DL, Rolfes MA, Meece JK, Pattinson D, Neumann G, Kawaoka Y, Belongia EA, McLean HQ. Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022. Influenza Other Respir Viruses. 17(3):e13104. https://doi.org/10.1111/irv.13104 (2023)

120. Uriu K, Ito J, Zahradnik J, Fujita S, Kosugi Y, Schreiber G, Genotype to Phenotype Japan (G2P-Japan) Consortium, Sato K. Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant. Lancet Infect Dis. 23(3):280-281. https://doi.org/10.1016/S1473-3099(23)00051-8 (2023)

論文解説　SARS-CoV-2オミクロンXBB.1.5株のウイルス学的性状の解明

121. Fukui A, Maruzuru Y, Takeshima K, Koyanagi N, Kato A, Kawaguchi Y. Establishment of a system to quantify wild-type herpes simplex virus-induced cell-cell fusion reveals a role of N-glycosylation of HSV-1 envelope glycoprotein B in cell-cell fusion. Microbiol Immunol. 67(3):114-119. https://doi.org/10.1111/1348-0421.13050 (2023)

122. Bramer LM, Hontz RD, Eisfeld AJ, Sims AC, Kim Y, Stratton KG, Nicora CD, Gritsenko MA, Schepmoes AA, Akasaka O, Koga M, Tsutsumi T, Nakamura M, Nakachi I, Baba R, Tateno H, Suzuki S, Nakajima H, Kato H, Ishida K, Ishii M, Uwamino Y, Mitamura K, Paurus VL, Nakayasu ES, Attah IK, Letizia AG, Waters KM, Metz TO, Corson K, Kawaoka Y, Gerbasi VR, Yotsuyanagi H, Iwatsuki-Horimoto K. Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections. Heliyon. 9(3):e13795. https://doi.org/10.1016/j.heliyon.2023.e13795 (2023)

123. Chazan A, Das I, Fujiwara T, Murakoshi S, Rozenberg A, Molina-Marquez A, Sano FK, Tanaka T, Gomez-Villegas P, Larom S, Pushkarev A, Malakar P, Hasegawa M, Tsukamoto Y, Ishizuka T, Konno M, Nagata T, Mizuno Y, Katayama K, Abe-Yoshizumi R, Ruhman S, Inoue K, Kandori H, Leon R, Shihoya W, Yoshizawa S, Sheves M, Nureki O, Beja O. Phototrophy by antenna-containing rhodopsin pumps in aquatic environments. Nature. 615(7952):535-540. https://doi.org/10.1038/s41586-023-05774-6 (2023)

124. Kiso M, Uraki R, Ito M, Yamayoshi S, Kotani Y, Imai M, Kohda N, Kawaoka Y. Oral intake of heat-killed Lactiplantibacillus pentosus ONRICb0240 partially protects mice against SARS-CoV-2 infection. Frontiers in Virology. 3:1137133. https://doi.org/10.3389/fviro.2023.1137133 (2023)

125. Kuchitsu Y, Mukai K, Uematsu R, Takaada Y, Shinojima A, Shindo R, Shoji T, Hamano S, Ogawa E, Sato R, Miyake K, Kato A, Kawaguchi Y, Nishitani-Isa M, Izawa K, Nishikomori R, Yasumi T, Suzuki T, Dohmae N, Uemura T, Barber GN, Arai H, Waguri S, Taguchi T. STING signalling is terminated through ESCRT-dependent microautophagy of vesicles originating from recycling endosomes. Nat Cell Biol. 25(3):453-466. https://doi.org/10.1038/s41556-023-01098-9 (2023)

126. Okamoto K, Takayanagi H. Effect of T cells on bone. Bone. 168:116675. https://doi.org/10.1016/j.bone.2023.116675 (2023)

127. Wijaya TJ, Yokota T, Lee S, Okano R, Kobayashi M, Someya T. Photostability Improvement of Organic Photodiodes with ZnO Electron Transport Layer. Adv Photon Res. 4(3) https://doi.org/10.1002/adpr.202200355 (2023)

128. Higashi-Kuwata N, Tsuji K, Hayashi H, Bulut H, Kiso M, Imai M, Ogata-Aoki H, Ishii T, Kobayakawa T, Nakano K, Takamune N, Kishimoto N, Hattori S, Das D, Uemura Y, Shimizu Y, Aoki M, Hasegawa K, Suzuki S, Nishiyama A, Saruwatari J, Shimizu Y, Sukenaga Y, Takamatsu Y, Tsuchiya K, Maeda K, Yoshimura K, Iida S, Ozono S, Suzuki T, Okamura T, Misumi S, Kawaoka Y, Tamamura H, Mitsuya H. Identification of SARS-CoV-2 M(pro) inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nat Commun. 14(1):1076-0. https://doi.org/10.1038/s41467-023-36729-0 (2023)

129. McLean HQ, Petrie JG, Hanson KE, Meece JK, Rolfes MA, Sylvester GC, Neumann G, Kawaoka Y, Belongia EA. Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness - Wisconsin, October 2022-February 2023. MMWR Morb Mortal Wkly Rep. 72(8):201-205. https://doi.org/10.15585/mmwr.mm7208a1 (2023)

130. Yotsuyanagi H, Ohmagari N, Doi Y, Imamura T, Sonoyama T, Ichihashi G, Sanaki T, Tsuge Y, Uehara T, Mukae H. A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part). Medicine (Baltimore). 102(8):e33024. https://doi.org/10.1097/MD.0000000000033024 (2023)

131. Nakayama T, Azegami T, Kiso M, Imai M, Uraki R, Hayashi K, Hishikawa A, Yoshimoto N, Nakamichi R, Sugita-Nishimura E, Yoshida-Hama E, Kawaoka Y, Itoh H. Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection. Sci Rep. 13(1):3103-8. https://doi.org/10.1038/s41598-023-30305-8 (2023)

132. Iwatsuki-Horimoto K, Ueki H, Ito M, Nagasawa S, Hirata Y, Hashizume K, Ushiwata K, Iwase H, Makino Y, Ushiku T, Akitomi S, Imai M, Saitoh H, Kawaoka Y. SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters. mSphere. 8(1):e0041122-22. Epub 2023 Jan 10. https://doi.org/10.1128/msphere.00411-22 (2023)

論文解説　SARS-CoV-2感染動物死体からのウイルス伝播

133. Yoshioka Y, Kobiyama K, Hayashi T, Onishi M, Yanagida Y, Nakagawa T, Hashimoto M, Nishinaka A, Hirose J, Asaoka Y, Tajiri M, Hayata A, Ishida S, Omoto S, Nagira M, Ishii KJ. A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via alpha-tocopherol component. Front Immunol. 14:1116238. https://doi.org/10.3389/fimmu.2023.1116238 (2023)

134. Best K, Ikeuchi K, Kater L, Best D, Musial J, Matsuo Y, Berninghausen O, Becker T, Inada T, Beckmann R. Structural basis for clearing of ribosome collisions by the RQT complex. Nat Commun. 14(1):921-8. https://doi.org/10.1038/s41467-023-36230-8 (2023)

論文解説　異常翻訳の実体である衝突リボソームの解消機構 ――mRNA引っ張り力によるリボソーム構造変化による異常翻訳解消機構――

135. Tesina P, Ebine S, Buschauer R, Thoms M, Matsuo Y, Inada T, Beckmann R. Molecular basis of eIF5A-dependent CAT tailing in eukaryotic ribosome-associated quality control. Mol Cell. 83(4):607-621.e4. https://doi.org/10.1016/j.molcel.2023.01.020 (2023)

論文解説　非典型翻訳反応における翻訳因子eIF5Aの機能の解明 ――mRNAを必要とせずにペプチド合成反応を行う仕組み――

136. Soga T, Duong C, Pattinson D, Sakai-Tagawa Y, Tokita A, Izumida N, Nishino T, Hagiwara H, Wada N, Miyamoto Y, Kuroki H, Hayashi Y, Seki M, Kasuya N, Koga M, Adachi E, Iwatsuki-Horimoto K, Yotsuyanagi H, Yamayoshi S, Kawaoka Y. Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018-2019 and 2019-2020 Influenza Seasons in Japan. Viruses. 15(2):535. https://doi.org/10.3390/v15020535 (2023)

137. Mahita J, Ha B, Gambiez A, Schendel SL, Li H, Hastie KM, Dennison SM, Li K, Kuzmina N, Periasamy S, Bukreyev A, Munt JE, Osei-Twum M, Atyeo C, Overton JA, Vita R, Guzman-Orozco H, Mendes M, Kojima M, Halfmann PJ, Kawaoka Y, Alter G, Gagnon L, Baric RS, Tomaras GD, Germann T, Bedinger D, Greenbaum JA, Saphire EO, Peters B. Coronavirus Immunotherapeutic Consortium Database. Database (Oxford). 2023:10.1093/database/baac112. https://doi.org/10.1093/database/baac112 (2023)

138. Sakuma M, Honda S, Ueno H, Tabata KV, Miyazaki K, Tokuriki N, Noji H. Genetic Perturbation Alters Functional Substates in Alkaline Phosphatase. Journal of the American Chemical Society. 145(5):2806–2814. https://doi.org/10.1021/jacs.2c06693 (2023) 

139. Miyashita R, Nishiyama A, Qin W, Chiba Y, Kori S, Kato N, Konishi C, Kumamoto S, Kozuka-Hata H, Oyama M, Kawasoe Y, Tsurimoto T, Takahashi TS, Leonhardt H, Arita K, Nakanishi M. The termination of UHRF1-dependent PAF15 ubiquitin signaling is regulated by USP7 and ATAD5. Elife. 12:10.7554/eLife.79013. https://doi.org/10.7554/eLife.79013 (2023)

140. Chen S, Quan DH, Sam G, Ozberk V, Wang XT, Halfmann P, Pandey M, Good MF, Kawaoka Y, Britton WJ, Rehm BHA. Assembly of Immunogenic Protein Particles toward Advanced Synthetic Vaccines. Small. 19(8):e2205819. https://doi.org/10.1002/smll.202205819 (2023)

141. Sugimori Y, Iwasaki Y, Takeshima Y, Okubo M, Kobayashi S, Hatano H, Yamada S, Nakano M, Yoshida R, Ota M, Tsuchida Y, Nagafuchi Y, Shimane K, Yoshida K, Kurosaka D, Sumitomo S, Shoda H, Yamamoto K, Okamura T, Fujio K. Transcriptome Profiling of Immune Cell Types in Peripheral Blood Reveals Common and Specific Pathways Involved in the Pathogenesis of Myositis-Specific Antibody-Positive Inflammatory Myopathies. ACR Open Rheumatol. 5(2):93-102. https://doi.org/10.1002/acr2.11521 (2023)

142. Watanabe N, Nakada-Tsukui K, Nozaki T. Molecular Dissection of Phagocytosis by Proteomic Analysis in Entamoeba histolytica. Genes. 14(2):379. https://doi.org/10.3390/genes14020379 (2023) 

143. Neumann G, Kawaoka Y. The COVID-19 Pandemic-A Potential Role for Antivirals in Mitigating Pandemics. Viruses. 15(2):303. https://doi.org/10.3390/v15020303 (2023)

144. Braun KM, Haddock Iii LA, Crooks CM, Barry GL, Lalli J, Neumann G, Watanabe T, Imai M, Yamayoshi S, Ito M, Moncla LH, Koelle K, Kawaoka Y, Friedrich TC. Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals. Virus Evol. 9(1):vead004. https://doi.org/10.1093/ve/vead004 (2023)

145. Ly MHP, Nguyen CT, Nguyen TV, Nguyen TTN, Nabeshima T, Adungo F, Takamatsu Y, Huy NT, Le TQM, Morita K, Hasebe F, Moi ML. Differential Infectivity of Human Neural Cell Lines by a Dengue Virus Serotype-3 Genotype-III with a Distinct Nonstructural Protein 2A (NS2A) Amino Acid Substitution Isolated from the Cerebrospinal Fluid of a Dengue Encephalitis Patient. Can J Infect Dis Med Microbiol. 2023:2635383. https://doi.org/10.1155/2023/2635383 (2023)

146. Muro R, Narita T, Nitta T, Takayanagi H. Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation. Front Immunol. 13:1045881. https://doi.org/10.3389/fimmu.2022.1045881 (2023)

147. Moritoyo T, Nishimura N, Hasegawa K, Ishii S, Kirihara K, Takata M, Svensson AK, Umeda-Kameyama Y, Kawarasaki S, Ihara R, Sakanaka C, Wakabayashi Y, Niizuma K, Tominaga T, Yamazaki T, Hasumi K. A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.15651 (2023)

148. Matsuo Y, Uchihashi T, Inada T. Decoding of the ubiquitin code for clearance of colliding ribosomes by the RQT complex. Nat Commun. 14(1):79-4. https://doi.org/10.1038/s41467-022-35608-4 (2023)

論文解説　リボソームの異常な交通渋滞を選別するしくみを解明 ――高速AFMを用いて品質管理を司る複合体の動きを可視化――

149. Minagawa Y, Nakata S, Date M, Ii Y, Noji H. On-Chip Enrichment System for Digital Bioassay Based on Aqueous Two-Phase System. ACS Nano. 17(1):212-220. https://doi.org/10.1021/acsnano.2c06007 (2023)

150. Neumann G, Kawaoka Y. Which Virus Will Cause the Next Pandemic? Viruses. 15(1):199. https://doi.org/10.3390/v15010199 (2023)

151. Yoshitaka Matsuo, Takayuki Uchihashi, Toshifumi Inada. Decoding of the ubiquitin code for clearance of colliding ribosomes by the RQT complex. Nature Communications. 14(1):79. https://doi.org/10.1038/s41467-022-35608-4 (2023) 

152. Chiba S, Hatta M, Pattinson D, Yasuhara A, Neumann G, Kawaoka Y. Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses. Vaccine. 41(2):590-597. https://doi.org/10.1016/j.vaccine.2022.12.005 (2023)

153. Imai M, Ito M, Kiso M, Yamayoshi S, Uraki R, Fukushi S, Watanabe S, Suzuki T, Maeda K, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Halfmann PJ, Kawaoka Y. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB. N Engl J Med. 388(1):89-91. https://doi.org/10.1056/NEJMc2214302 (2023)

論文解説　臨床検体から分離した新型コロナウイルス・オミクロン株の BQ.1.1系統とXBB系統に対する治療薬の効果を検証

154. Jin J, Ogawa T, Hojo N, Kryukov K, Shimizu K, Ikawa T, Imanishi T, Okazaki T, Shiroguchi K. Robotic data acquisition with deep learning enables cell image-based prediction of transcriptomic phenotypes. Proc Natl Acad Sci U S A. 120(1):e2210283120. https://doi.org/10.1073/pnas.2210283120 (2023)

155. Takashita E, Watanabe S, Hasegawa H, Kawaoka Y. Are twindemics occurring? Influenza Other Respir Viruses. 17(1):e13090. https://doi.org/10.1111/irv.13090 (2023)

論文解説　新型コロナウイルス感染症とインフルエンザが同時流行しているかを検証

156. Bae C, Katoh H, Wakata A, Sakata M, Kato F, Takeda M. Demonstration of bacterium-free very rapid reverse genetics system using mumps virus. Microbiol Immunol. 67(1):44-47. https://doi.org/10.1111/1348-0421.13032 (2023)

157. Koga M, Iwatsuki-Horimoto K, Kikuchi T, Yamayoshi S, Kawaoka Y, Yotsuyanagi H. Previous omicron infection may be protective against reinfection with omicron variant BA.5 for at least 5 months. Clin Microbiol Infect. 29(1):120-121. https://doi.org/10.1016/j.cmi.2022.09.009 (2023)

158. Uraki R, Ito M, Furusawa Y, Yamayoshi S, Iwatsuki-Horimoto K, Adachi E, Saito M, Koga M, Tsutsumi T, Yamamoto S, Otani A, Kiso M, Sakai-Tagawa Y, Ueki H, Yotsuyanagi H, Imai M, Kawaoka Y. Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB. Lancet Infect Dis. 23(1):30-32. https://doi.org/10.1016/S1473-3099(22)00816-7 (2023)

論文解説　ワクチン被接種者あるいはブレイクスルー感染者血漿の、 臨床検体から分離した新型コロナウイルス・オミクロン株の BQ.1.1系統とXBB系統に対する反応性を検証

159. Furuya G, Katoh H, Atsumi S, Hashimoto I, Komura D, Hatanaka R, Senga S, Hayashi S, Akita S, Matsumura H, Miura A, Mita H, Nakakido M, Nagatoishi S, Sugiyama A, Suzuki R, Konishi H, Yamamoto A, Abe H, Hiraoka N, Aoki K, Kato Y, Seto Y, Yoshimura C, Miyadera K, Tsumoto K, Ushiku T, Ishikawa S. Nucleic acid-triggered tumoral immunity propagates pH-selective therapeutic antibodies through tumor-driven epitope spreading. Cancer Sci. 114(1):321-338. https://doi.org/10.1111/cas.15596 (2023)

160. Atsumi Y, Toriyama M, Kato H, Nakamura M, Morita A, Takaishi M, Saito K, Tanaka M, Okada F, Tominaga M, Ishii KJ, Fujita F. Anti-Inflammatory Role of TRPV4 in Human Macrophages. Immunohorizons. 7(1):81-96. https://doi.org/10.4049/immunohorizons.2200100 (2023) 

161. 塚崎 雅之, 高柳 広. 【最新の骨粗鬆症学(第2版)-骨粗鬆症学の最新知見-】骨研究フロンティア　骨代謝を調節する微細環境　免疫系. 日臨. 81(増刊1 最新の骨粗鬆症学):111-117. (2023) 

162. 鶴町 真也, 平野 利忠, 山田 泰広. 生体内リプログラミングによる膵島細胞の増殖誘導. 医学のあゆみ. 284(11):885-889. (2023) https://cir.nii.ac.jp/crid/1520577215748432768

2022

1. Tomomatsu S, Watanabe A, Tesina P, Hashimoto S, Ikeuchi K, Li S, Matsuo Y, Beckmann R, Inada T. Two modes of Cue2-mediated mRNA cleavage with distinct substrate recognition initiate no-go decay. Nucleic Acids Res. 51(1):253-270. https://doi.org/10.1093/nar/gkac1172 (2022)

論文解説　リボソーム衝突に依存したmRNAの内部切断の仕組み

2. Eiden J, Fierro C, Schwartz H, Adams M, Ellis KJ, Aitchison R, Herber R, Hatta Y, Marshall D, Moser MJ, Belshe R, Greenberg H, Coelingh K, Kawaoka Y, Neumann G, Bilsel P. Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults. J Infect Dis. 227(1):103-112. https://doi.org/10.1093/infdis/jiac433 (2022)

3. Takeshita M, Fukuyama H, Kamada K, Matsumoto T, Makino-Okamura C, Uchikubo-Kamo T, Tomabechi Y, Hanada K, Moriyama S, Takahashi Y, Ishigaki H, Nakayama M, Nguyen CT, Kitagawa Y, Itoh Y, Imai M, Maemura T, Furusawa Y, Ueki H, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Kawaoka Y, Shirouzu M, Ishii M, Saya H, Kondo Y, Kaneko Y, Suzuki K, Fukunaga K, Takeuchi T. Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models. iScience. 25(12):105596. https://doi.org/10.1016/j.isci.2022.105596 (2022)

4. Takeshima K, Maruzuru Y, Koyanagi N, Kato A, Kawaguchi Y. Redundant and Specific Roles of A-Type Lamins and Lamin B Receptor in Herpes Simplex Virus 1 Infection. J Virol. 96(24):1429. https://doi.org/10.1128/jvi.01429-22 (2022)

5. Ishimura R, El-Gowily AH, Noshiro D, Komatsu-Hirota S, Ono Y, Shindo M, Hatta T, Abe M, Uemura T, Lee-Okada H, Mohamed TM, Yokomizo T, Ueno T, Sakimura K, Natsume T, Sorimachi H, Inada T, Waguri S, Noda NN, Komatsu M. The UFM1 system regulates ER-phagy through the ufmylation of CYB5R3. Nat Commun. 13(1):7857-0. https://doi.org/10.1038/s41467-022-35501-0 (2022)

6. Kawasaki T, Ikegawa M, Yunoki K, Otani H, Ori D, Ishii KJ, Kuroda E, Takamura S, Kitabatake M, Ito T, Isotani A, Kawai T. Alveolar macrophages instruct CD8(+) T cell expansion by antigen cross-presentation in lung. Cell Rep. 41(11):111828. https://doi.org/10.1016/j.celrep.2022.111828 (2022)

7. Sarawar S, Gabaglia CR, Sanchez A, Hatta Y, Dias P, Neumann G, Kawaoka Y, Bilsel P. Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice. Vaccines (Basel). 10(12):2131. doi: 10.3390/vaccines10122131. https://doi.org/10.3390/vaccines10122131 (2022)

8. Ohe S, Kubota Y, Yamaguchi K, Takagi Y, Nashimoto J, Kozuka-Hata H, Oyama M, Furukawa Y, Takekawa M. ERK-mediated NELF-A phosphorylation promotes transcription elongation of immediate-early genes by releasing promoter-proximal pausing of RNA polymerase II. Nat Commun. 13(1):7476-4. https://doi.org/10.1038/s41467-022-35230-4 (2022)

論文解説　細胞増殖と発癌を司る初期応答遺伝子群の新たな発現調節機構の解明 ―増殖シグナルがRNAポリメラーゼIIの転写伸長反応を制御する仕組みを発見―

9. Boon ACM, Darling TL, Halfmann PJ, Franks J, Webby RJ, Barouch DH, Port JR, Munster VJ, Diamond MS, Kawaoka Y. Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters. PLoS Pathog. 18(12):e1010970. https://doi.org/10.1371/journal.ppat.1010970 (2022)

10. Uraki R, Halfmann PJ, Iida S, Yamayoshi S, Furusawa Y, Kiso M, Ito M, Iwatsuki-Horimoto K, Mine S, Kuroda M, Maemura T, Sakai-Tagawa Y, Ueki H, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Pekosz A, Kandeil A, Webby RJ, Wang Z, Imai M, Suzuki T, Kawaoka Y. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents. Nature. 612(7940):540-545. https://doi.org/10.1038/s41586-022-05482-7 (2022)

論文解説　患者から分離した新型コロナウイルス・オミクロン変異株のBA.4系統ならびにBA.5系統の性状解明

11. Tsukamoto Y, Kurogi S, Shibata T, Suzuki K, Hirashita Y, Fumoto S, Yano S, Yanagihara K, Nakada C, Mieno F, Kinoshita K, Fuchino T, Mizukami K, Ueda Y, Etoh T, Uchida T, Hanada T, Takekawa M, Daa T, Shirao K, Hironaka S, Murakami K, Inomata M, Hijiya N, Moriyama M. Enhanced phosphorylation of c-Jun by cisplatin treatment as a potential predictive biomarker for cisplatin response in combination with patient-derived tumor organoids. Lab Invest. 102(12):1355-1366. https://doi.org/10.1038/s41374-022-00827-2 (2022)

12. Takashita E, Yamayoshi S, Halfmann P, Wilson N, Ries H, Richardson A, Bobholz M, Vuyk W, Maddox R, Baker DA, Friedrich TC, O'Connor DH, Uraki R, Ito M, Sakai-Tagawa Y, Adachi E, Saito M, Koga M, Tsutsumi T, Iwatsuki-Horimoto K, Kiso M, Yotsuyanagi H, Watanabe S, Hasegawa H, Imai M, Kawaoka Y. In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6. N Engl J Med. 387(22):2094-2097. https://doi.org/10.1056/NEJMc2211845 (2022)

13. Murakami S, Kitamura T, Matsugo H, Kamiki H, Oyabu K, Sekine W, Takenaka-Uema A, Sakai-Tagawa Y, Kawaoka Y, Horimoto T. Isolation of Bat Sarbecoviruses, Japan. Emerg Infect Dis. 28(12):2500-2503. https://doi.org/10.3201/eid2812.220801 (2022)

14. Halfmann PJ, Frey SJ, Loeffler K, Kuroda M, Maemura T, Armbrust T, Yang JE, Hou YJ, Baric R, Wright ER, Kawaoka Y, Kane RS. Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses. EBioMedicine. 86:104341. https://doi.org/10.1016/j.ebiom.2022.104341 (2022)

15. Hata K, Kobayashi N, Sugimura K, Qin W, Haxholli D, Chiba Y, Yoshimi S, Hayashi G, Onoda H, Ikegami T, Mulholland CB, Nishiyama A, Nakanishi M, Leonhardt H, Konuma T, Arita K. Structural basis for the unique multifaceted interaction of DPPA3 with the UHRF1 PHD finger. Nucleic Acids Res. 50(21):12527-12542. https://doi.org/10.1093/nar/gkac1082 (2022)

16. Nagai H, Saito M, Adachi E, Sakai-Tagawa Y, Yamayoshi S, Kiso M, Kawamata T, Koga M, Kawaoka Y, Tsutsumi T, Yotsuyanagi H. Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy. Jpn J Infect Dis. 75(6):608-611. https://doi.org/10.7883/yoken.JJID.2022.092 (2022)

17. Otsubo R, Minamitani T, Kobiyama K, Fujita J, Ito T, Ueno S, Anzai I, Tanino H, Aoyama H, Matsuura Y, Namba K, Imadome K, Ishii KJ, Tsumoto K, Kamitani W, Yasui T. Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein. Sci Rep. 12(1):20120-4. https://doi.org/10.1038/s41598-022-24730-4 (2022)

18. Kikuchi A, Onoda H, Yamaguchi K, Kori S, Matsuzawa S, Chiba Y, Tanimoto S, Yoshimi S, Sato H, Yamagata A, Shirouzu M, Adachi N, Sharif J, Koseki H, Nishiyama A, Nakanishi M, Defossez P, Arita K. Structural basis for activation of DNMT1. Nat Commun. 13(1):7130-4. https://doi.org/10.1038/s41467-022-34779-4 (2022)

19. Halfmann PJ, Minor NR, Haddock Iii LA, Maddox R, Moreno GK, Braun KM, Baker DA, Riemersa KK, Prasad A, Alman KJ, Lambert MC, Florek K, Bateman A, Westergaard R, Safdar N, Andes DR, Kawaoka Y, Fida M, Yao JD, Friedrich TC, O'Connor DH. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual. Virus Evol. 9(2):veac104. https://doi.org/10.1093/ve/veac104 (2022)

20. Yasuhara A, Yamayoshi S, Kiso M, Sakai-Tagawa Y, Okuda M, Kawaoka Y. A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases. Nat Commun. 13(1):6602-0. https://doi.org/10.1038/s41467-022-34521-0 (2022)

21. Wang T, Johmura Y, Suzuki N, Omori S, Migita T, Yamaguchi K, Hatakeyama S, Yamazaki S, Shimizu E, Imoto S, Furukawa Y, Yoshimura A, Nakanishi M. Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes. Nature. 611(7935):358-364. https://doi.org/10.1038/s41586-022-05388-4 (2022)

論文解説　抗PD1抗体は老化細胞の免疫監視を強化し、老年病・生活習慣病を改善する

22. Hanata N, Ota M, Tsuchida Y, Nagafuchi Y, Okamura T, Shoda H, Fujio K. Serum extracellular traps associate with the activation of myeloid cells in SLE patients with the low level of anti-DNA antibodies. Sci Rep. 12(1):18397. https://doi.org/10.1038/s41598-022-23076-1 (2022)

23. Yamayoshi S, Iwatsuki-Horimoto K, Okuda M, Ujie M, Yasuhara A, Murakami J, Duong C, Hamabata T, Ito M, Chiba S, Kobayashi R, Takahashi S, Mitamura K, Hagihara M, Shibata A, Uwamino Y, Hasegawa N, Ebina T, Izumi A, Kato H, Nakajima H, Sugaya N, Seki Y, Iqbal A, Kamimaki I, Yamazaki M, Kawaoka Y, Furuse Y. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022. Emerg Infect Dis. 28(11):2198-2205. https://doi.org/10.3201/eid2811.221127 (2022)

24. Narita M, Denk T, Matsuo Y, Sugiyama T, Kikuguchi C, Ito S, Sato N, Suzuki T, Hashimoto S, Machova I, Tesina P, Beckmann R, Inada T. A distinct mammalian disome collision interface harbors K63-linked polyubiquitination of uS10 to trigger hRQT-mediated subunit dissociation. Nat Commun. 13(1):6411. https://doi.org/10.1038/s41467-022-34097-9 (2022)

論文解説　哺乳類においてリボソームの衝突に対処する仕組み ―ユビキチン修飾を介した翻訳停滞の解消を試験管内で再現―

25. Futamata H, Fukuda M, Umeda R, Yamashita K, Tomita A, Takahashi S, Shikakura T, Hayashi S, Kusakizako T, Nishizawa T, Homma K, Nureki O. Cryo-EM structures of thermostabilized prestin provide mechanistic insights underlying outer hair cell electromotility. Nat Commun. 13(1):6208-x. https://doi.org/10.1038/s41467-022-34017-x (2022)

26. Ohta M, Kambayashi Y, Mita H, Kuroda T, Bannai H, Tsujimura K, Yamanaka T, Garvey M, Cullinane A, Yamayoshi S, Kawaoka Y, Nemoto M. Protective efficacy of a reverse genetics-derived inactivated vaccine against equine influenza virus in horses. Vaccine. 40(44):6362-6366. https://doi.org/10.1016/j.vaccine.2022.09.047 (2022)